|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
JPS5896026A
(ja)
|
1981-10-30 |
1983-06-07 |
Nippon Chemiphar Co Ltd |
新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
|
|
US4609546A
(en)
|
1982-06-24 |
1986-09-02 |
Japan Chemical Research Co., Ltd. |
Long-acting composition
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
JPH01207920A
(ja)
|
1988-02-16 |
1989-08-21 |
Oki Electric Ind Co Ltd |
ＩｎＰ半導体薄膜の製造方法
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5270202A
(en)
|
1989-11-03 |
1993-12-14 |
Syamal Raychaudhuri |
Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
IE911869A1
(en)
|
1990-06-01 |
1991-12-04 |
Regeneron Pharma |
A family of map2 protein kinases
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5780587A
(en)
|
1990-08-24 |
1998-07-14 |
President And Fellows Of Harvard College |
Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
|
|
MX9205293A
(es)
|
1991-09-20 |
1993-05-01 |
Syntex Sinergen Neuroscience J |
Factores neurotrofico derivado del glial
|
|
US5412087A
(en)
|
1992-04-24 |
1995-05-02 |
Affymax Technologies N.V. |
Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
|
|
AU3178993A
(en)
|
1991-11-25 |
1993-06-28 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
WO1993011231A1
(en)
|
1991-12-06 |
1993-06-10 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Tools for the diagnosis and treatment of alzheimer's disease
|
|
US5624807A
(en)
|
1992-07-22 |
1997-04-29 |
The Mclean Hospital Corporation |
Methods for detecting Alzheimer's disease by measuring ratios of calcium-activated neutral protease isoforms
|
|
EP0672142B1
(en)
|
1992-12-04 |
2001-02-28 |
Medical Research Council |
Multivalent and multispecific binding proteins, their manufacture and use
|
|
WO1994021293A1
(en)
|
1993-03-19 |
1994-09-29 |
Duke University |
Method of treatment of tumors with an antibody binding to tenascin
|
|
ES2173130T3
(es)
|
1993-10-20 |
2002-10-16 |
Univ Duke |
Metodo de fijacion de material al peptido beta-amiloide.
|
|
US5985660A
(en)
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
|
CU22615A1
(es)
|
1994-06-30 |
2000-02-10 |
Centro Inmunologia Molecular |
Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
|
|
ATE306930T1
(de)
|
1994-08-12 |
2005-11-15 |
Immunomedics Inc |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
|
JPH10504961A
(ja)
|
1994-08-26 |
1998-05-19 |
ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド |
Ｇａｂａ▲下ａ▼レセプターイプシロンサブユニット
|
|
KR100275591B1
(ko)
|
1994-10-28 |
2001-02-01 |
크리스타 헤르 조크 |
단백질 키나아제 npk-110
|
|
US6835555B1
(en)
|
1994-11-01 |
2004-12-28 |
Human Genome Sciences, Inc. |
Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
|
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
|
DE4447287C1
(de)
|
1994-12-30 |
1996-11-07 |
Cevc Gregor |
Präparat zum Wirkstofftransport durch Barrieren
|
|
US5650313A
(en)
|
1995-06-05 |
1997-07-22 |
Human Genome Sciences, Inc. |
Ubiquitin conjugating enzymes 8 and 9
|
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
|
GB9506197D0
(en)
|
1995-03-27 |
1995-05-17 |
Hoffmann La Roche |
Inhibition of tau-tau association.
|
|
US6576607B1
(en)
|
1995-04-19 |
2003-06-10 |
Acorda Therapeutics |
Methods using CNS neurite outgrowth modulators
|
|
US5986054A
(en)
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
US6221645B1
(en)
|
1995-06-07 |
2001-04-24 |
Elan Pharmaceuticals, Inc. |
β-secretase antibody
|
|
DE69635207T2
(de)
|
1995-07-07 |
2006-06-22 |
Darwin Molecular Corp. |
Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
|
|
US6156311A
(en)
|
1995-07-27 |
2000-12-05 |
The American National Red Cross |
Modulators of expression and function of LRP in alzheimer's disease
|
|
US5695937A
(en)
|
1995-09-12 |
1997-12-09 |
The Johns Hopkins University School Of Medicine |
Method for serial analysis of gene expression
|
|
FR2741892B1
(fr)
|
1995-12-04 |
1998-02-13 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus
|
|
US5936078A
(en)
|
1995-12-12 |
1999-08-10 |
Kyowa Hakko Kogyo Co., Ltd. |
DNA and protein for the diagnosis and treatment of Alzheimer's disease
|
|
AUPN896596A0
(en)
|
1996-03-27 |
1996-04-26 |
Walter And Eliza Hall Institute Of Medical Research, The |
Therapeutic molecules
|
|
CA2250075C
(en)
|
1996-03-29 |
2008-06-10 |
The Trustees Of Boston University |
Methods for diagnosing and treating alzheimer's disease
|
|
US6455277B1
(en)
|
1996-04-22 |
2002-09-24 |
Amgen Inc. |
Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
|
|
US5663059A
(en)
|
1996-05-10 |
1997-09-02 |
Incyte Pharmaceuticals, Inc. |
Human phospholipase inhibitor
|
|
US6010878A
(en)
|
1996-05-20 |
2000-01-04 |
Smithkline Beecham Corporation |
Interleukin-1 β converting enzyme like apoptotic protease-6
|
|
CA2183901A1
(en)
|
1996-08-22 |
1998-02-23 |
Johanna E. Bergmann |
Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
|
|
CA2279231C
(en)
|
1997-02-07 |
2013-11-26 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Activity dependent neurotrophic factor iii (adnf iii)
|
|
US6413940B1
(en)
|
1997-02-07 |
2002-07-02 |
Nymox Corporation |
Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS
|
|
US6087153A
(en)
|
1997-07-24 |
2000-07-11 |
The Trustees Of Columbia University In The City Of New York |
Sel-10 and uses thereof
|
|
IT1293511B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati
|
|
US7384910B2
(en)
|
1997-10-08 |
2008-06-10 |
Castillo Gerardo M |
Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
|
|
US6242421B1
(en)
|
1997-11-06 |
2001-06-05 |
Richard Lloyd Bowen |
Methods for preventing and treating Alzheimer's disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US7189703B2
(en)
|
1998-01-09 |
2007-03-13 |
Intracell, Llc |
Treatment and diagnosis of alzheimer's disease
|
|
GB9816575D0
(en)
|
1998-07-31 |
1998-09-30 |
Zeneca Ltd |
Novel compounds
|
|
DE69931791T2
(de)
|
1998-08-06 |
2007-05-24 |
Teijin Ltd. |
Pharmazeutische zusammensetzung die ein inhibierendes effekt auf die überproduktion und akkumulation der extrazellulären matrix hat
|
|
US20050032675A1
(en)
|
1998-08-06 |
2005-02-10 |
Teijin Limited |
Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
|
|
GB9818731D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Compounds
|
|
GB9818730D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Collections of compounds
|
|
DK1193270T3
(da)
|
1998-08-27 |
2003-09-15 |
Spirogen Ltd |
Pyrrolobenzodiazepiner
|
|
BR9913850A
(pt)
|
1998-09-17 |
2001-10-23 |
Otsuka Pharma Co Ltd |
Gene ly6h
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
JP2002531815A
(ja)
|
1998-12-02 |
2002-09-24 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
オキシダント・ストレス症候群および疾病における脂質の過酸化のレベルを決定する方法および組成物
|
|
US6982089B2
(en)
|
1999-02-24 |
2006-01-03 |
Tact Ip, Llc |
Cytokine antagonists for neurological and neuropsychiatric disorders
|
|
DE19909357A1
(de)
|
1999-03-03 |
2000-09-07 |
Gerd Multhaup |
Kupferagonist, der an die Kupferbindungsstelle von APP bindet und/oder eine hemmende Wirkung auf die Freisetzung des Amyloid-Aß-Peptids ausübt
|
|
DE19910108C2
(de)
|
1999-03-08 |
2001-02-22 |
Falk Fahrenholz |
Zellen, die ein Amyloidvorläuferprotein und eine alpha-Sekretase coexprimieren, ein Testverfahren zur Identifikation alpha-Sekretase-aktiver Substanzen sowie eines zur Identifikation weiterer Sekretasen, ein Testverfahren zur Bestimmung der Anfälligkeit gegenüber Morbus Alzheimer und Verwendung von Nukleinsäuren, die für eine alpha-Sekretase codieren, für die Gentherapie
|
|
WO2000062076A1
(en)
|
1999-04-13 |
2000-10-19 |
Hsu Daniel K |
Galectin expression is induced in cirrhotic liver and hepatocellular carcinoma
|
|
US6303576B1
(en)
|
1999-04-21 |
2001-10-16 |
Adherex Technologies Inc. |
Compounds and methods for modulating β-catenin mediated gene expression
|
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
WO2001004300A1
(fr)
|
1999-07-08 |
2001-01-18 |
Helix Research Institute |
Facteur associe a l'apoptose
|
|
EP1074634B1
(en)
|
1999-07-09 |
2002-10-02 |
Institut Pasteur De Lille |
Method for the diagnosis or the prognosis of Alzheimer disease therapeutical composition for preventing or treating Alzheimer disease
|
|
DK1255824T3
(da)
|
1999-08-06 |
2010-07-19 |
S I S S A Scuola Internaz Supe |
Transgene mus til undersøgelse af neurodegenerative syndromer
|
|
AU784568B2
(en)
|
1999-09-03 |
2006-05-04 |
Ramot At Tel-Aviv University Ltd |
Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
|
|
US6255054B1
(en)
|
1999-09-09 |
2001-07-03 |
Jacques Hugon |
Polymorphism of the human GluR-5 gene and risk factor for alzheimer disease
|
|
ATE294859T1
(de)
|
1999-09-17 |
2005-05-15 |
Univ Keio |
Polypeptid, humanin, welches das absterben von nervenzellen hemmt
|
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
|
CN1241940C
(zh)
|
2000-02-14 |
2006-02-15 |
株式会社Bf研究所 |
新型胶原蛋白样蛋白clac、其前体和它们的编码基因
|
|
KR100767146B1
(ko)
|
2000-02-24 |
2007-10-15 |
워싱톤 유니버시티 |
Ａβ 펩티드를 격리시키는 인간화 항체
|
|
AU2001243622A1
(en)
|
2000-03-13 |
2001-09-24 |
La Jolla Institute For Allergy And Immunology |
Monocyte chemoattractant activity of galectin-3
|
|
US20060148712A1
(en)
|
2000-03-13 |
2006-07-06 |
Fu-Tong Liu |
Monocyte chemoattractant activity of galectin-3
|
|
AU2001268828C1
(en)
|
2000-06-28 |
2006-12-14 |
Prana Biotechnology Limited |
Neurotoxic oligomers
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
AU2001268005A1
(en)
|
2000-07-07 |
2002-01-21 |
Lars Lannfelt |
Prevention and treatment of alzheimer's disease
|
|
US6825164B1
(en)
|
2000-08-14 |
2004-11-30 |
The Trustees Of Columbia University In The City Of New York |
Method to increase cerebral blood flow in amyloid angiopathy
|
|
CA2392004C
(en)
|
2000-09-20 |
2005-11-29 |
Matsushita Electric Industrial Co., Ltd. |
Probe for scanning probe microscope and method for producing the same, and scanning probe microscope including the probe and molecular processing method using the scanning probe microscope
|
|
US7471798B2
(en)
*
|
2000-09-29 |
2008-12-30 |
Knowles Electronics, Llc |
Microphone array having a second order directional pattern
|
|
KR100395254B1
(ko)
|
2000-10-30 |
2003-08-21 |
(주)자리타 바이오텍 |
종양 발생 예측 키트
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7320793B2
(en)
|
2001-01-19 |
2008-01-22 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
|
ES2305234T3
(es)
|
2001-02-27 |
2008-11-01 |
Blanchette Rockefeller Neurosciences Institute |
Diagnostico de la enfermedad de alzheimer basado en la fosforilacion de una proteina quinosa activada por mitogeno.
|
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
|
EP1379882B1
(en)
|
2001-04-14 |
2008-07-16 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders
|
|
ATE420114T1
(de)
|
2001-04-30 |
2009-01-15 |
Lilly Co Eli |
Humanisierte antikörper die das beta-amyloid peptid erkennen& x9;
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6906169B2
(en)
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
|
DE10130247A1
(de)
|
2001-06-22 |
2003-01-16 |
Elegene Ag I Ins |
Identifizierung von ses-3 sowie dessen Verwendungen
|
|
DE10130166A1
(de)
|
2001-06-22 |
2003-01-16 |
Elegene Ag I Ins |
Identifizierung von ses-1 sowie dessen Verwendungen
|
|
US6831699B2
(en)
|
2001-07-11 |
2004-12-14 |
Chang Industry, Inc. |
Deployable monitoring device having self-righting housing and associated method
|
|
DE60226036T9
(de)
|
2001-08-03 |
2016-09-29 |
Medical & Biological Laboratories Co., Ltd. |
ANTIKÖRPER, DER DAS GM1-GANGLIOSID-GEBUNDENE AMYLOID-b-PROTEIN ERKENNT, UND DNA, DIE FÜR DIESEN ANTIKÖRPER CODIERT
|
|
ATE464567T1
(de)
|
2001-09-07 |
2010-04-15 |
Takeda Pharmaceutical |
Diagnostische und therapeutische verwendung von f-box-proteinen bei morbus alzheimer und verwandten neurodegenerativen erkrankungen
|
|
US6716821B2
(en)
|
2001-12-21 |
2004-04-06 |
Immunogen Inc. |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
|
|
DE60303360T2
(de)
|
2002-02-14 |
2006-09-21 |
Evotec Neurosciences Gmbh |
Diagnostische und therapeutische verwendung des caps
|
|
AU2003208212A1
(en)
|
2002-03-04 |
2003-09-16 |
Nymox Corporation |
Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
|
|
AU2003225636A1
(en)
|
2002-03-05 |
2003-09-22 |
Ramot At Tel-Aviv University Ltd. |
Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
AU2003215667A1
(en)
|
2002-03-21 |
2003-10-08 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
|
|
NZ536064A
(en)
|
2002-04-19 |
2008-06-30 |
Univ Toronto |
Immunological methods and compositions for the treatment of alzheimer's disease
|
|
WO2003091734A1
(en)
|
2002-04-24 |
2003-11-06 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases
|
|
US20050032673A1
(en)
|
2002-06-10 |
2005-02-10 |
John Constance M. |
Sustained release N-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating disease
|
|
AU2003245589A1
(en)
|
2002-06-21 |
2004-01-06 |
Reuven Avrohom Cyrulnik |
System and method for noninvasive diagnostic imaging
|
|
DE60317671T2
(de)
|
2002-06-27 |
2008-10-30 |
Evotec Neurosciences Gmbh |
Diagnostische und therapeutische verwendung von ensadin-0581 gen und protein für neurodegenerative erkrankungen
|
|
US7141137B2
(en)
|
2002-07-10 |
2006-11-28 |
University Of Maine System Board Of Trustees |
Method of making laminated wood beams with varying lamination thickness throughout the thickness of the beam
|
|
JP4414332B2
(ja)
|
2002-07-12 |
2010-02-10 |
アクソン・ニューロサイエンス・フォルシュングス−ウント・エントヴィックルングス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
アルツハイマーｔａｕタンパク質を発現するトランスジェニック動物
|
|
RU2450827C2
(ru)
|
2002-07-19 |
2012-05-20 |
Цитос Биотехнологи Аг |
Композиции вакцин, содержащие наборы антигенов в виде амилоида бета 1-6
|
|
CA2802205C
(en)
|
2002-07-31 |
2016-01-19 |
Seattle Genetics, Inc. |
Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
MXPA05003621A
(es)
|
2002-10-09 |
2005-10-19 |
Rinat Neuroscience Corp |
Metodos de tratamiento de la enfermedad de alzheimer usando anticuerpos dirigidos contra el peptido beta amiloide y composiciones de los mismos.
|
|
AT413945B
(de)
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
|
PL378571A1
(pl)
|
2003-02-01 |
2006-05-02 |
Neuralab Limited |
Czynna immunizacja dla wytworzenia przeciwciał przeciw rozpuszczalnemu A-ß
|
|
WO2004070388A1
(en)
|
2003-02-04 |
2004-08-19 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases
|
|
DE602004027348D1
(de)
|
2003-02-10 |
2010-07-08 |
Applied Molecular Evolution |
Abeta-bindende moleküle
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
US20040223971A1
(en)
*
|
2003-04-07 |
2004-11-11 |
Glycogenesys, Inc. |
Composition and uses of galectin antagonists
|
|
AU2004229399B2
(en)
|
2003-04-07 |
2010-08-05 |
Prospect Therapeutics, Inc. |
Composition and uses of galectin antagonists
|
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
|
ES2246177B1
(es)
|
2003-05-08 |
2007-03-01 |
Universidad De Zaragoza. |
Uso de anticuerpos para el tratamiento de enfermedades amiloideas.
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
PE20050627A1
(es)
|
2003-05-30 |
2005-08-10 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
|
WO2004111654A2
(en)
|
2003-06-06 |
2004-12-23 |
Ciphergen Biosystems, Inc. |
Serum biomarkers in ischaemic heart disease
|
|
JP4888876B2
(ja)
|
2003-06-13 |
2012-02-29 |
田平 武 |
アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター
|
|
US7384523B2
(en)
|
2003-07-10 |
2008-06-10 |
Radiometer Medical Aps |
Chloride ion selective membrane and sensor
|
|
MXPA06001107A
(es)
|
2003-07-28 |
2006-04-11 |
Sig Technology Ltd |
Cierre vertedor con un arreglo de borde perforador para envases combinados o recipientes sellados con material de papel metalizado.
|
|
JP4448134B2
(ja)
|
2003-08-08 |
2010-04-07 |
シェーリング コーポレイション |
ベンズアミド置換基を有する環状アミンｂａｓｅ−１阻害剤
|
|
AR045219A1
(es)
|
2003-08-08 |
2005-10-19 |
Pharmacopeia Inc |
Aminas ciclicas inhibidoras de base - 1 que poseen un sustiuyente heterociclico
|
|
EP1669085B1
(en)
|
2003-09-05 |
2015-01-07 |
Hisamitsu Pharmaceutical Co., Inc. |
Medical agent for prevention and/or treatment of alzheimer disease
|
|
AT413336B
(de)
|
2003-09-12 |
2006-02-15 |
Mattner Frank Dr |
Apherese-vorrichtung
|
|
EP1670943B1
(en)
|
2003-09-30 |
2013-11-13 |
Evotec International GmbH |
Diagnostic and therapeutic use of a sulfotransferase for alzheimer's disease
|
|
US7700823B2
(en)
|
2003-10-02 |
2010-04-20 |
Aventis Pharma S.A. |
Transgenic animals exhibiting major disorders related to Alzheimer's disease
|
|
BRPI0414924A
(pt)
*
|
2003-10-03 |
2006-11-07 |
Brigham & Womens Hospital |
ligantes de tim-3 e seus métodos
|
|
GB0416511D0
(en)
|
2003-10-22 |
2004-08-25 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
JP2007514406A
(ja)
|
2003-10-29 |
2007-06-07 |
エヴォテック ニューロサイエンシス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ヒトｄａｘ−１遺伝子およびタンパク質の神経変性疾患に関する診断的および治療的使用
|
|
ME01775B
(me)
|
2003-11-05 |
2011-02-28 |
Glycart Biotechnology Ag |
Cd20 antitijela sa povećanim afinitetom vezivanja za fc receptor i efektornom funkcijom
|
|
NZ583292A
(en)
|
2003-11-06 |
2012-03-30 |
Seattle Genetics Inc |
Monomethylvaline compounds capable of conjugation to ligands
|
|
WO2005058352A2
(en)
|
2003-12-17 |
2005-06-30 |
Entelos, Inc. |
Treatment of rheumatoid arthritis with galectin-3 antagonists
|
|
PT1697370E
(pt)
|
2003-12-19 |
2007-05-31 |
Bristol Myers Squibb Co |
Heterociclos azabicíclicos como moduladores do receptor de canabinóides
|
|
JP4824547B2
(ja)
|
2004-02-20 |
2011-11-30 |
インテレクト ニュウロサイエンシス，インク． |
モノクローナル抗体およびその利用
|
|
US8060179B1
(en)
|
2006-11-16 |
2011-11-15 |
Scientific Nanomedicine, Inc. |
Biomagnetic detection and treatment of Alzheimer's Disease
|
|
US20070166718A1
(en)
|
2004-03-03 |
2007-07-19 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
|
|
JP5166861B2
(ja)
|
2004-03-09 |
2013-03-21 |
スピロゲン リミティッド |
ピロロベンゾジアゼピン
|
|
US20050239836A1
(en)
|
2004-03-09 |
2005-10-27 |
Varghese John |
Substituted hydroxyethylamine aspartyl protease inhibitors
|
|
EP1741783A4
(en)
|
2004-04-27 |
2009-05-27 |
Chemo Sero Therapeut Res Inst |
HUMAN ANTIAMYLOID BETA PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF
|
|
US7629443B2
(en)
|
2004-06-02 |
2009-12-08 |
New York Blood Center, Inc. |
Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
|
|
WO2005123048A2
(en)
|
2004-06-21 |
2005-12-29 |
Proteome Sciences Plc |
Screening methods using c-abl, fyn and syk in combination with tau protein
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
CN1969277A
(zh)
|
2004-07-07 |
2007-05-23 |
三菱电机株式会社 |
电力计算装置、电力计算方法、抗侵害性评价装置和抗侵害性评价方法
|
|
AT413946B
(de)
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
|
AT500483B1
(de)
|
2004-07-13 |
2006-01-15 |
Mattner Frank Dr |
Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
|
|
US7955812B2
(en)
|
2004-07-19 |
2011-06-07 |
The General Hospital Corporation |
Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers
|
|
US20060024667A1
(en)
|
2004-07-29 |
2006-02-02 |
Karen Manucharyan |
Compositions and methods for Alzheimer's disease
|
|
AR050184A1
(es)
|
2004-07-28 |
2006-10-04 |
Schering Corp |
Inhibidores macrociclicos de beta-secretasa
|
|
MX2007001559A
(es)
|
2004-08-03 |
2007-04-10 |
Transtech Pharma Inc |
Proteinas de fusion de receptor para productos finales glicados avanzados y metodos de uso.
|
|
US20080301821A1
(en)
|
2004-08-11 |
2008-12-04 |
Evotec Neurosciences Gmbh |
Diagnostic and Therapeutic use of a Plasma Membrane Atpase
|
|
AU2005272396A1
(en)
|
2004-08-11 |
2006-02-16 |
Mitsubishi Chemical Corporation |
Antibody and utilization of the same
|
|
GB0421639D0
(en)
|
2004-09-29 |
2004-10-27 |
Proteome Sciences Plc |
Methods and compositions relating to alzheimer's disease
|
|
WO2006037800A1
(en)
|
2004-10-08 |
2006-04-13 |
Université de Liège |
COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE
|
|
US9907485B2
(en)
|
2004-10-15 |
2018-03-06 |
Brainlab Ag |
Targeted immunization and plaque destruction against Alzheimer's disease
|
|
WO2006055178A2
(en)
|
2004-10-25 |
2006-05-26 |
Merck & Co., Inc. |
Anti-addl antibodies and uses thereof
|
|
AU2005332660A1
(en)
|
2004-11-12 |
2006-12-14 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the N terminus
|
|
EP1838854B1
(en)
|
2004-12-15 |
2012-10-31 |
Janssen Alzheimer Immunotherapy |
Antibodies that recognize Beta Amyloid Peptide
|
|
US8257740B1
(en)
|
2011-08-15 |
2012-09-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US20060257359A1
(en)
|
2005-02-28 |
2006-11-16 |
Cedric Francois |
Modifying macrophage phenotype for treatment of disease
|
|
US7632634B2
(en)
|
2005-04-15 |
2009-12-15 |
University Of Maryland Biotechnology Institute |
Method and assay for early diagnosis of prostate cancer
|
|
EP1891215B1
(en)
|
2005-04-20 |
2009-10-28 |
Dnavec Corporation |
Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
|
|
AU2006238686B2
(en)
|
2005-04-21 |
2011-10-06 |
Medimmune Limited |
Pyrrolobenzodiazepines
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
BRPI0610093A2
(pt)
|
2005-05-05 |
2008-12-09 |
Merck & Co Inc |
composiÇço farmacÊutica, e, mÉtodo para prevenir ou tratar uma doenÇa associada com os depàsitos de amilàides de alfa-beta no cÉrebro de um paciente
|
|
CN109485727A
(zh)
|
2005-05-09 |
2019-03-19 |
小野药品工业株式会社 |
程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法
|
|
WO2006128879A1
(en)
|
2005-05-30 |
2006-12-07 |
Takeda Pharmaceutical Company Limited |
Diagnostic and therapeutic target prkx proteins for neurodegenerative diseases
|
|
US20090133135A1
(en)
|
2005-06-01 |
2009-05-21 |
Evotec Neurosciences Gmbh |
Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases
|
|
ES2436795T3
(es)
|
2005-06-14 |
2014-01-07 |
Merck Sharp & Dohme Corp. |
Inhibidores heterocíclicos de aspartil proteasa, preparación y uso de los mismos
|
|
DE602006018456D1
(de)
|
2005-06-14 |
2011-01-05 |
Schering Corp |
Herstellung und verwendung von verbindungen als aspartylproteasehemmer
|
|
ATE495269T1
(de)
|
2005-06-16 |
2011-01-15 |
Evotec Neurosciences Gmbh |
Adarb2 proteine als diagnostische und therapeutische targets für neurodegenerative erkrankungen
|
|
CA2611054C
(en)
|
2005-06-17 |
2017-05-09 |
National Research Council Of Canada |
Novel a.beta.-binding polypeptides and derivatives and uses thereof
|
|
DE102005029729A1
(de)
|
2005-06-24 |
2006-12-28 |
Röchling Automotive AG & Co. KG |
Verkleidungs- oder Gehäuseteil eines Fahrzeugs und Verfahren zu seiner Herstellung
|
|
US8871720B2
(en)
|
2005-07-07 |
2014-10-28 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
|
|
US20070021282A1
(en)
|
2005-07-19 |
2007-01-25 |
Karp Shaun A |
Abdominal exercising and strength testing systems
|
|
WO2007022416A2
(en)
|
2005-08-18 |
2007-02-22 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
|
WO2007027559A2
(en)
|
2005-08-29 |
2007-03-08 |
Shashoua Victor E |
Neuroprotective and neurorestorative methods and compositions
|
|
US9133267B2
(en)
|
2005-11-22 |
2015-09-15 |
The Trustees Of The University Of Pennsylvania |
Antibody treatment of Alzheimer's and related diseases
|
|
MX2008006957A
(es)
|
2005-11-30 |
2008-10-20 |
Abbott Lab |
Metodos para la preparacion de formas recombinantes de proteina beta-amiloide humana y usos de estas proteinas.
|
|
SG10201706600VA
(en)
|
2005-11-30 |
2017-09-28 |
Abbvie Inc |
Monoclonal antibodies and uses thereof
|
|
DK1813614T3
(da)
|
2006-01-25 |
2012-01-23 |
Sanofi Sa |
Cytotoksiske midler, der omfatter nye tomaymycinderivater
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
CA2638775A1
(en)
|
2006-02-22 |
2007-08-30 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Peptide vaccine for inducing production of anti-amyloid-.beta.-peptide antibody
|
|
AU2007219615B2
(en)
|
2006-03-03 |
2013-11-28 |
Promis Neurosciences Inc. |
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
|
|
EP2005187A4
(en)
|
2006-03-23 |
2010-04-21 |
Life Technologies Corp |
METHOD AND REAGENTS FOR IN VIVO IMAGING CANCER CELL LINES
|
|
BRPI0709050B1
(pt)
|
2006-03-23 |
2018-12-26 |
Bioarctic Neuroscience Ab |
anticorpo ou fragmento do mesmo, composição, métodos para detectar protofibrilas ab in vitro, e, uso do anticorpo
|
|
US8012936B2
(en)
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
WO2007129457A1
(ja)
|
2006-04-25 |
2007-11-15 |
The University Of Tokyo |
アルツハイマー病および癌の治療薬
|
|
WO2008042024A2
(en)
|
2006-06-01 |
2008-04-10 |
Elan Pharmaceuticals, Inc. |
Neuroactive fragments of app
|
|
WO2008004346A1
(fr)
|
2006-07-06 |
2008-01-10 |
Nec Corporation |
Procédé et dispositif de conception d'une hiérarchie de circuit intégré semi-conducteur
|
|
WO2008022349A2
(en)
|
2006-08-18 |
2008-02-21 |
Armagen Technologies, Inc. |
Agents for blood-brain barrier delivery
|
|
WO2008029886A1
(en)
|
2006-09-06 |
2008-03-13 |
National University Corporation Tottori University |
Kit for diagnosis of alzheimer's disease, diagnostic marker, and method for detection of indicator for disease condition
|
|
WO2008036717A2
(en)
*
|
2006-09-19 |
2008-03-27 |
Emory University |
Use of soluble galectin-3 (gal-3) for cancer treatment
|
|
WO2008085564A2
(en)
|
2006-09-20 |
2008-07-17 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods involving truncated recombinant seven g-protein coupled receptors
|
|
CA2668693A1
(en)
|
2006-11-15 |
2008-05-22 |
David E. Anderson |
Therapeutic uses of tim-3 modulators
|
|
US8420613B2
(en)
|
2006-11-15 |
2013-04-16 |
The J. David Gladstone Institutes |
Methods and compositions for reducing amyloid beta levels
|
|
GB0624500D0
(en)
|
2006-12-07 |
2007-01-17 |
Istituto Superiore Di Sanito |
A novel passive vaccine for candida infections
|
|
US8420591B2
(en)
|
2006-12-08 |
2013-04-16 |
Dana-Farber Cancer Institute, Inc. |
MUC1 and galectin-3
|
|
EP3225251B1
(en)
|
2006-12-21 |
2020-02-12 |
H. Lundbeck A/S |
Modulation of activity of proneurotrophins
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
NO2740744T3
(enExample)
|
2007-01-09 |
2018-08-25 |
|
|
|
AU2008204335B2
(en)
|
2007-01-11 |
2013-06-13 |
Michael Bacher |
Diagnosis and treatment of Alzheimer's and other neurodementing diseases
|
|
ES2535641T3
(es)
|
2007-01-18 |
2015-05-13 |
Eli Lilly & Company |
Amiloide beta Fab pegilado
|
|
WO2008112559A1
(en)
|
2007-03-09 |
2008-09-18 |
Regents Of The University Of California |
Suppression of galectin-3 for treating an inflammatory condition
|
|
TR201802286T4
(tr)
|
2007-04-20 |
2018-03-21 |
The Chemo Sero Therapeutic Res Institute |
Peptidle bağışıklık yanıtının arttırılması için yöntem.
|
|
EP2152744A4
(en)
|
2007-04-26 |
2012-02-15 |
Univ Yale |
PRION PROTEIN AS RECEPTOR FOR AMYLOID-BETA OLIGOMERS
|
|
WO2008133772A1
(en)
|
2007-04-26 |
2008-11-06 |
Ludwig Institute For Cancer Research |
Method for modulating activity of t lymphocytes
|
|
EP2152309B1
(en)
|
2007-05-14 |
2013-07-10 |
Medtronic, Inc. |
Methods and device to neutralize soluble toxic agents in the brain
|
|
BRPI0814256A8
(pt)
|
2007-07-05 |
2016-02-10 |
Schering Corp |
Inibidores de tetrahidropiranocromeno gama secretase
|
|
AU2008276492A1
(en)
|
2007-07-17 |
2009-01-22 |
Merck Sharp & Dohme Corp. |
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
|
|
DK2019104T3
(da)
|
2007-07-19 |
2013-12-16 |
Sanofi Sa |
Cytotoksiske midler, der omfatter nye tomaymycinderivater, og terapeutisk anvendelse deraf
|
|
JP5889529B2
(ja)
|
2007-07-27 |
2016-03-22 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
アミロイド原性疾患の処置
|
|
US8993833B2
(en)
|
2007-08-14 |
2015-03-31 |
Duke University |
Model of Alzheimer's Disease
|
|
US9370531B2
(en)
|
2007-08-31 |
2016-06-21 |
New York University |
Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
|
|
EP2200990A1
(en)
|
2007-09-06 |
2010-06-30 |
Schering Corporation |
Gamma secretase modulators
|
|
EP2527369A3
(en)
|
2007-09-13 |
2012-12-19 |
University Of Zurich Prorektorat Forschung |
Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
|
|
WO2009057664A1
(ja)
|
2007-10-29 |
2009-05-07 |
Mitsubishi Chemical Corporation |
抗体及びその利用
|
|
NZ585000A
(en)
|
2007-10-29 |
2012-08-31 |
Inst Nat Sante Rech Med |
New antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs
|
|
US20100306868A1
(en)
|
2007-11-01 |
2010-12-02 |
Bernd Bohrmann |
Quadruple transgenic non-human animal
|
|
WO2009061699A1
(en)
|
2007-11-05 |
2009-05-14 |
Schering Corporation |
Gamma secretase modulators
|
|
KR101397554B1
(ko)
|
2007-11-09 |
2014-05-21 |
재단법인서울대학교산학협력재단 |
치매(알츠하이머 병)의 진단, 예방, 치료제 및 이들의스크리닝 방법
|
|
CA2705292C
(en)
|
2007-11-13 |
2016-06-21 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against tl1a
|
|
ME01026B
(me)
|
2007-11-16 |
2012-10-20 |
Univ Rockefeller |
Antitijela specifična za protofibrilni oblik beta-amiloid proteina
|
|
US8349579B2
(en)
|
2007-12-13 |
2013-01-08 |
Wayne State University |
Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer
|
|
WO2009087689A2
(en)
|
2008-01-07 |
2009-07-16 |
Council Of Scientific & Industrial Research |
Novel primers for identification of astrocytoma, it's grades and glioblastoma prognosis
|
|
ITNA20080006A1
(it)
|
2008-01-28 |
2009-07-29 |
Consiglio Nazionale Ricerche |
Proteine chimeriche capaci di formare particelle virus-like, che contengono sequenze peptidiche del beta-amiloide e la componente e2 della alfachetoacido deidrogenasi di "geobacillus stearothermophilus", utili per l'induzione di una risposta anticorp
|
|
CA2714413C
(en)
|
2008-02-08 |
2017-01-24 |
Immunas Pharma, Inc. |
Antibody capable of binding specifically to ab-oligomer, and use thereof
|
|
US8852874B2
(en)
|
2008-02-29 |
2014-10-07 |
Baxter International Inc. |
Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
|
|
FR2929292A1
(fr)
|
2008-03-28 |
2009-10-02 |
Exonhit Therapeutics S A Sa |
Procede et methodes de diagnostic de la maladie d'alzheimer
|
|
US9908943B2
(en)
|
2008-04-03 |
2018-03-06 |
Vib Vzw |
Single domain antibodies capable of modulating BACE activity
|
|
CN102065881B
(zh)
|
2008-04-14 |
2014-03-12 |
埃尔奇诺瓦公司 |
稳定的淀粉样beta单体和寡聚体
|
|
KR101603917B1
(ko)
|
2008-05-09 |
2016-03-17 |
애브비 인코포레이티드 |
최종 당화 산물의 수용체(ｒａｇｅ)에 대한 항체 및 이의 용도
|
|
EP2299812B1
(en)
|
2008-05-27 |
2017-07-12 |
Yale University |
Targeting tgf-beta as a therapy for alzheimer's disease
|
|
US8969023B2
(en)
|
2008-06-10 |
2015-03-03 |
Eleanore Bennett Charitable Trust #2 |
Methods and compositions for treating alzheimer's disease
|
|
US8933295B2
(en)
|
2008-06-20 |
2015-01-13 |
Janssen Biotech, Inc. |
Identifying agents to treat alzheimer's disease-related decreased sorting behavior by administration to a triple transgenic mouse expressing mutant forms of APP, presenilin or tau
|
|
WO2009155609A1
(en)
|
2008-06-20 |
2009-12-23 |
Oklahoma Medical Research Foundation |
IMMUNOGENIC MEMAPSIN 2 β-SECRETASE PEPTIDES AND METHODS OF USE
|
|
MX345039B
(es)
|
2008-06-25 |
2017-01-16 |
Esbatech Alcon Biomed Res Unit |
Anticuerpos estables y solubles que inhiben el tnfa.
|
|
ES2397641T3
(es)
|
2008-07-01 |
2013-03-08 |
De Staat Der Nederlanden, Vert. Door De Minister Van Vws |
Vacuna contra el intermediario de plegado amiloide
|
|
WO2010005858A1
(en)
|
2008-07-08 |
2010-01-14 |
Merck & Co., Inc. |
Vaccine for the treatment of alzheimer's disease
|
|
SG192485A1
(en)
|
2008-07-08 |
2013-08-30 |
Incyte Corp |
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
|
|
GB0813432D0
(en)
|
2008-07-22 |
2008-08-27 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
NZ710443A
(en)
|
2008-08-12 |
2019-03-29 |
Zinfandel Pharmaceuticals Inc |
Method of identifying disease risk factors
|
|
US8283322B2
(en)
|
2008-08-15 |
2012-10-09 |
Orthopeutics, Lp |
Formulations for nonsurgical exogenous crosslink therapy
|
|
CA2739076A1
(en)
|
2008-10-02 |
2010-04-08 |
Celtaxsys, Inc. |
Methods of modulating the negative chemotaxis of immune cells
|
|
CA2742265C
(en)
|
2008-10-29 |
2014-07-15 |
Bg Medicine, Inc. |
Galectin-3 immunoassay
|
|
US7888035B2
(en)
|
2008-10-30 |
2011-02-15 |
Caris Mpi, Inc. |
Methods for assessing RNA patterns
|
|
US8809318B2
(en)
|
2008-11-13 |
2014-08-19 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
JP5503663B2
(ja)
|
2008-11-13 |
2014-05-28 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ガンマセクレターゼモジュレータ
|
|
DE102008037564A1
(de)
|
2008-11-19 |
2010-05-20 |
Forschungszentrum Jülich GmbH |
Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden
|
|
US8912145B2
(en)
|
2008-11-28 |
2014-12-16 |
Hokko Chemical Industry Co., Ltd. |
Vaccine composition for prophylaxis and/or therapy of Alzheimer's disease
|
|
EP3115063A3
(en)
*
|
2008-12-03 |
2017-04-19 |
The John Hopkins University |
Galectin-3 and annexin-a2 as immunological target
|
|
US20120046181A1
(en)
|
2008-12-19 |
2012-02-23 |
Chu Nantes |
Biomarkers for the Diagnosis of Renal Allograft and Kidney Status
|
|
US8759337B2
(en)
|
2008-12-22 |
2014-06-24 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
US20100196882A1
(en)
*
|
2009-02-04 |
2010-08-05 |
Avraham Raz |
GALECTIN-3 nsSNP MARKER FOR CANCER
|
|
US8426402B2
(en)
|
2009-02-05 |
2013-04-23 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
|
FR2942476B1
(fr)
|
2009-02-20 |
2013-03-15 |
Commissariat Energie Atomique |
Composes de type pyridocarbazole et leurs applications
|
|
SI2408807T1
(sl)
|
2009-03-18 |
2021-11-30 |
Ac Immune Sa |
Postopek za terapevtsko uporabo
|
|
US9173928B2
(en)
|
2009-03-26 |
2015-11-03 |
Yoh Matsumoto |
DNA vaccine for Alzheimer's disease
|
|
JP2010268789A
(ja)
|
2009-04-24 |
2010-12-02 |
Kumamoto Univ |
細胞医薬の製造方法
|
|
FR2945538B1
(fr)
|
2009-05-12 |
2014-12-26 |
Sanofi Aventis |
Anticorps humanises specifiques de la forme protofibrillaire du peptide beta-amyloide.
|
|
EP2258398A1
(en)
|
2009-05-26 |
2010-12-08 |
Araclón Biotech, S. L. |
Albumin-amyloid peptide conjugates and uses thereof
|
|
EP4218794A3
(en)
|
2009-06-10 |
2023-09-13 |
New York University |
Immunological targeting of pathological tau proteins
|
|
JP5944822B2
(ja)
|
2009-06-15 |
2016-07-05 |
フエー・イー・ベー・フエー・ゼツト・ウエー |
Ｂａｃｅ１抑制性抗体
|
|
US20120238546A1
(en)
|
2009-06-16 |
2012-09-20 |
Zhaoning Zhu |
Gamma secretase modulators
|
|
PT2448968T
(pt)
|
2009-06-29 |
2021-04-30 |
Bioarctic Ab |
ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINAL
|
|
EP2273273A1
(en)
|
2009-07-11 |
2011-01-12 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Inhibitors of the nitration of amyloid ß peptides and their uses in the diagnosis and treatment of alzheimer's disease
|
|
CN102439727B
(zh)
|
2009-07-15 |
2015-05-20 |
富士电机株式会社 |
超结半导体器件
|
|
JP5769316B2
(ja)
|
2009-08-06 |
2015-08-26 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
JP5051806B2
(ja)
|
2009-08-07 |
2012-10-17 |
協和発酵キリン株式会社 |
抗アミロイドβオリゴマーヒト化抗体
|
|
KR20120104167A
(ko)
|
2009-08-25 |
2012-09-20 |
비쥐 메디신, 인코포레이티드 |
갈렉틴―3 및 심장 재동기화 요법
|
|
WO2011026031A1
(en)
|
2009-08-28 |
2011-03-03 |
The Board Of Regents Of The University Of Texas System |
Antibodies that bind tau oligomers
|
|
WO2011031720A1
(en)
|
2009-09-11 |
2011-03-17 |
Arizona Board Of Regents Acting For And On Behalf Of Arizona State University |
Bispecific nanobodies as a therapeutic for alzheimer's disease
|
|
DE102009043750A1
(de)
|
2009-09-30 |
2011-08-04 |
Carl Zeiss Meditec AG, 07745 |
Verfahren und Vorrichtung zur Detektion von Ablagerungen im Auge
|
|
JPWO2011045945A1
(ja)
|
2009-10-16 |
2013-03-04 |
国立大学法人京都大学 |
アミロイドβのターン構造を認識する抗体
|
|
WO2011102901A1
(en)
|
2010-02-20 |
2011-08-25 |
Ebiotec (Euroespes Biotechnology) |
Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphingosine-1-phosphate
|
|
RU2644335C2
(ru)
|
2010-03-03 |
2018-02-08 |
Зе Юниверсити Оф Бритиш Коламбия |
Эпитоп, специфичный к олигомеру амилоида бета, и антитела
|
|
WO2011119842A1
(en)
|
2010-03-25 |
2011-09-29 |
The J. David Gladstone Institutes |
Compositions and methods for treating neurological disorders
|
|
SG184820A1
(en)
|
2010-04-13 |
2012-11-29 |
Baxter Int |
Use of ventricular enlargement rate in intravenous immunoglobulin treatment of alzheimer's disease
|
|
NZ602932A
(en)
|
2010-04-15 |
2014-08-29 |
Seattle Genetics Inc |
Targeted pyrrolobenzodiazapine conjugates
|
|
CN102971329B
(zh)
|
2010-04-15 |
2016-06-29 |
麦迪穆有限责任公司 |
用于治疗增殖性疾病的吡咯并苯并二氮杂卓
|
|
JP5904939B2
(ja)
|
2010-05-25 |
2016-04-20 |
株式会社島津製作所 |
大腸がんマーカーガレクチン、採血試料中のガレクチン濃度の分析方法及び大腸がんマーカーガレクチン検出キット
|
|
EP2580326A1
(en)
|
2010-06-11 |
2013-04-17 |
Antisense Pharma GmbH |
Method for selective oligonucleotide modification
|
|
JP5934203B2
(ja)
|
2010-07-14 |
2016-06-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
抗ａｄｄｌモノクローナル抗体およびこの使用
|
|
US10420923B1
(en)
|
2010-08-10 |
2019-09-24 |
Amiram Katz |
Method and device for intrathecal administering of immunoglobulin
|
|
LT3042917T
(lt)
|
2010-08-12 |
2018-05-10 |
Eli Lilly And Company |
Antikūnai prieš n3pglu beta amiloidinį peptidą ir jų panaudojimas
|
|
WO2012036786A1
(en)
|
2010-09-17 |
2012-03-22 |
University Of L'aquila |
Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of alzheimer's disease
|
|
CA2816681A1
(en)
|
2010-11-03 |
2012-05-10 |
Immunogen, Inc. |
Cytotoxic agents comprising new ansamitocin derivatives
|
|
WO2012066495A2
(en)
|
2010-11-17 |
2012-05-24 |
Ben Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
|
EA034333B1
(ru)
|
2010-11-30 |
2020-01-29 |
Дженентек, Инк. |
Варианты антитела для переноса соединения через гематоэнцефалический барьер
|
|
WO2012091138A1
(ja)
|
2010-12-28 |
2012-07-05 |
大日本住友製薬株式会社 |
アルツハイマー病の診断薬及び診断方法
|
|
WO2012106363A2
(en)
|
2011-01-31 |
2012-08-09 |
Intellect Neurosciences Inc. |
Treatment of tauopathies
|
|
CN103718046B
(zh)
|
2011-03-17 |
2016-10-12 |
重症监护诊断股份有限公司 |
预测不良临床结果的风险的方法
|
|
EP2508212A1
(en)
|
2011-04-05 |
2012-10-10 |
Universitätsklinikum Freiburg |
Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support
|
|
WO2012136552A1
(en)
|
2011-04-08 |
2012-10-11 |
H. Lundbeck A/S |
ANTIBODIES SPECIFIC TO PYROGLUTAMATED Αβ
|
|
KR101589135B1
(ko)
|
2011-04-20 |
2016-01-29 |
주식회사 셀앤바이오 |
인간화 항-ｅｍａｐｉｉ 항체 및 이의 용도
|
|
AU2012250496A1
(en)
|
2011-05-03 |
2013-11-28 |
Commonwealth Scientific And Industrial Research Organisation |
Method for detection of a neurological disease
|
|
GB201108490D0
(en)
|
2011-05-18 |
2011-07-06 |
Ucl Business Plc |
Methods and uses
|
|
WO2012159027A2
(en)
|
2011-05-19 |
2012-11-22 |
President And Fellows Of Harvard College |
Osw-1 analogs and conjugates, and uses thereof
|
|
AR086543A1
(es)
*
|
2011-05-25 |
2014-01-08 |
Bg Medicine Inc |
Inhibidores de galectina-3 y metodos de uso de los mismos, composicion farmaceutica
|
|
CA2836927A1
(en)
|
2011-06-21 |
2012-12-27 |
Immunogen, Inc. |
Novel maytansinoid derivatives with peptide linker and conjugates thereof
|
|
WO2013008402A1
(ja)
|
2011-07-08 |
2013-01-17 |
シャープ株式会社 |
薄膜トランジスタ基板及びそれを備えた表示装置
|
|
GB201113482D0
(en)
|
2011-08-04 |
2011-09-21 |
Univ Liverpool |
Assay
|
|
PT2748201T
(pt)
|
2011-08-23 |
2018-02-08 |
Roche Glycart Ag |
Moléculas de ligação ao antigénio biespecíficas que ativam as células t
|
|
SMT201800109T1
(it)
|
2011-09-19 |
2018-05-02 |
Axon Neuroscience Se |
Terapia a base di proteine e diagnosi di una patologia mediata da tau nella malattia di alzheimer
|
|
CN103957937B
(zh)
|
2011-09-19 |
2017-06-06 |
约翰内斯堡威特沃特斯兰德大学 |
用于治疗阿尔茨海默病的化合物
|
|
ES2754304T3
(es)
|
2011-09-23 |
2020-04-16 |
Siemens Healthcare Diagnostics Inc |
Ensayo de respuesta celular para detectar cáncer y métodos de producción y uso del mismo
|
|
JP6393617B2
(ja)
|
2011-10-14 |
2018-09-19 |
シアトル ジェネティクス，インコーポレーテッド |
ピロロベンゾジアゼピンおよび標的コンジュゲート
|
|
US9549953B2
(en)
|
2011-12-08 |
2017-01-24 |
Eliaz Therapeutics, Inc. |
Galectin-3 plasmapheresis therapy
|
|
EP2788761B1
(en)
|
2011-12-08 |
2018-02-28 |
Eliaz Therapeutics, Inc. |
Reduction of galectin-3 levels by plasmapheresis
|
|
US8764695B2
(en)
|
2012-09-28 |
2014-07-01 |
Isaac Eliaz |
Reduction of galectin-3 levels by plasmapheresis
|
|
AU2012351963A1
(en)
|
2011-12-15 |
2014-06-26 |
The United States of America, as represented by Secretary, Department of Health & Human Services |
Identification of two novel biomarkers for Niemann-Pick disease type C
|
|
US20130164217A1
(en)
|
2011-12-21 |
2013-06-27 |
Meso Scale Technologies, Llc |
Method of diagnosing, preventing and/or treating dementia & related disorders
|
|
KR101948400B1
(ko)
|
2011-12-29 |
2019-02-14 |
타오 헬스 라이프 파마 가부시키가이샤 |
아밀로스페로이드가 결합하여 성숙 신경 세포사를 유발하는 표적 분자, 아밀로스페로이드가 유도하는 신경 세포사를 억제하는 방법 및 물질, 및 그들의 이용
|
|
WO2013106572A1
(en)
|
2012-01-11 |
2013-07-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
|
CN107982548A
(zh)
|
2012-02-07 |
2018-05-04 |
全球生物疗法有限公司 |
核酸输送的区室化方法及其组合物和应用
|
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
|
EP2819700B1
(en)
|
2012-02-27 |
2016-12-21 |
Universitat de Barcelona |
Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs
|
|
ITRM20120383A1
(it)
|
2012-03-20 |
2013-09-21 |
Uni Degli Studi Di Milano B Icocca |
Metodo e kit per la rivelazione di anticorpi.
|
|
ES2819174T3
(es)
|
2012-03-26 |
2021-04-15 |
Yeda Res & Dev |
Marcadores celulares para el diagnóstico de la enfermedad de Alzheimer y para la progresión de la enfermedad de Alzheimer
|
|
RU2644242C2
(ru)
|
2012-04-05 |
2018-02-08 |
Ац Иммуне С.А. |
Гуманизированное тау-антитело
|
|
WO2013152313A1
(en)
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
WO2013169890A1
(en)
|
2012-05-08 |
2013-11-14 |
Bg Medicine, Inc. |
Systems and methods for assessing disease risk, status, and prognosis
|
|
EP3269736B1
(en)
|
2012-05-10 |
2019-11-27 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Conformational-specific antibodies against oligomers of amyloid beta
|
|
EP2849797B1
(en)
|
2012-05-15 |
2019-12-18 |
Concortis Biosystems, Corp |
Drug-conjugates, conjugation methods, and uses thereof
|
|
US9682143B2
(en)
|
2012-08-14 |
2017-06-20 |
Ibc Pharmaceuticals, Inc. |
Combination therapy for inducing immune response to disease
|
|
FR2994803B1
(fr)
*
|
2012-08-30 |
2016-02-26 |
Oreal |
Modulation de la forme des fibres keratiniques
|
|
US9655977B2
(en)
|
2012-08-31 |
2017-05-23 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of alzheimer's disease
|
|
MX2015002947A
(es)
|
2012-09-07 |
2015-09-23 |
Genentech Inc |
Terapia de combinacion de un anticuerpo ant-cd20 tipo ii con un inhibidor blc-2 selectivo.
|
|
BR112015005772A2
(pt)
*
|
2012-09-17 |
2017-08-08 |
Galectin Therapeutics Inc |
método para a intensificação de imunoterapias específicas no tratamento de câncer
|
|
JP6306596B2
(ja)
|
2012-10-04 |
2018-04-04 |
リサーチ ディベロップメント ファウンデーション |
セリンプロテアーゼ分子および療法
|
|
ES2802873T3
(es)
|
2012-10-15 |
2021-01-21 |
Medimmune Ltd |
Anticuerpos a beta amiloide
|
|
CA2892490A1
(en)
|
2012-11-26 |
2014-05-30 |
Caris Science, Inc. |
Biomarker compositions and methods
|
|
US9066928B1
(en)
|
2012-12-04 |
2015-06-30 |
University Of Kentucky Research Foundation |
Method, composition, and kit useful for treatment of alzheimer's disease
|
|
US9089614B2
(en)
|
2012-12-21 |
2015-07-28 |
Bioalliance C.V. |
Hydrophilic self-immolative linkers and conjugates thereof
|
|
US9433665B2
(en)
|
2013-01-11 |
2016-09-06 |
Cyvax, Inc. |
Vaccines for protection from and treatment of alzheimer's disease
|
|
EP2955195B1
(en)
|
2013-02-06 |
2019-03-27 |
Yokohama City University |
Anti-semaphorin 3a antibody and treatment of alzheimer's disease and inflammatory immune diseases using same
|
|
DK2961426T3
(da)
|
2013-02-26 |
2019-12-02 |
Baxalta GmbH |
Behandling af sygdomme i centralnervesystemet ved intranasal indgivelse af immunoglobulin g
|
|
RU2015140915A
(ru)
|
2013-02-26 |
2017-04-03 |
Роше Гликарт Аг |
Биспецифические антигенсвязывающие молекулы, активирующие т-клетки
|
|
EP3666795A1
(en)
|
2013-03-12 |
2020-06-17 |
Molecular Templates, Inc. |
Cytotoxic proteins comprising cell-targeting binding regions and shiga toxin a subunit regions for selective killing of specific cell types
|
|
CN105307685B
(zh)
|
2013-03-13 |
2019-03-08 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓和其结合物
|
|
EP2777714A1
(en)
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
US9688747B2
(en)
|
2013-03-15 |
2017-06-27 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
AU2013203043B2
(en)
|
2013-03-15 |
2016-10-06 |
Takeda Pharmaceutical Company Limited |
Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
|
|
US9879076B2
(en)
|
2013-03-15 |
2018-01-30 |
Ramot At Tel Aviv University Ltd. |
Methods and compositions with immune therapy for treatment of dementia
|
|
WO2014160871A2
(en)
|
2013-03-27 |
2014-10-02 |
The General Hospital Corporation |
Methods and agents for treating alzheimer's disease
|
|
AU2014262890B2
(en)
|
2013-05-06 |
2019-01-31 |
Takeda Pharmaceutical Company Limited |
Treatment of Alzheimer's disease subpopulations with pooled immunoglobulin G
|
|
JP2016520615A
(ja)
|
2013-05-31 |
2016-07-14 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
アルツハイマー病を処置するためのｉｌ−１アンタゴニストを使用する方法
|
|
EP3013355B1
(en)
|
2013-06-25 |
2019-08-07 |
ICM - Institut du Cerveau et da la Moelle Epinière |
Il-2 for use in treating alzheimer disease and related disorders
|
|
WO2015031084A1
(en)
|
2013-08-28 |
2015-03-05 |
Jianfeng Cai |
Methods of synthesizing y-aapeptides, y-aapeptide building blocks, y-aapeptide libraries, and y-aapeptide inhibitors of ab40 aggregates
|
|
EP3043802B1
(en)
|
2013-09-13 |
2018-04-18 |
Merck Sharp & Dohme Corp. |
C5-spiro iminothiazine dioxides as bace inhibitors, compositions, and their use
|
|
WO2015038426A1
(en)
|
2013-09-13 |
2015-03-19 |
Asana Biosciences, Llc |
Self-immolative linkers containing mandelic acid derivatives, drug-ligand conjugates for targeted therapies and uses thereof
|
|
WO2015051850A1
(en)
|
2013-10-11 |
2015-04-16 |
Universität Für Bodenkultur Wien |
Compositions containing galectin-3 modulators for the treatment of bone disorders
|
|
WO2015057876A1
(en)
|
2013-10-15 |
2015-04-23 |
Sorrento Therapeutics Inc. |
Drug-conjugates with a targeting molecule and two different drugs
|
|
GB201319761D0
(en)
|
2013-11-08 |
2013-12-25 |
Nordic Bioscience As |
Biomarkers of disease progression
|
|
CA2932958A1
(en)
|
2013-12-20 |
2015-06-25 |
F. Hoffmann-La Roche Ag |
Humanized anti-tau(ps422) antibodies and methods of use
|
|
CA2930330A1
(en)
|
2013-12-27 |
2015-07-02 |
Dignity Health |
Diagnosing and treating alzheimer's disease
|
|
US10272083B2
(en)
|
2014-01-21 |
2019-04-30 |
Acerta Pharma B.V. |
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
|
|
US20160177284A1
(en)
|
2014-01-27 |
2016-06-23 |
Molecular Templates, Inc. |
Cell-targeted molecules comprising amino-terminus proximal or amino-terminal shiga toxin a subunit effector regions
|
|
US20210138076A2
(en)
|
2014-01-27 |
2021-05-13 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes
|
|
EP3575312A1
(en)
|
2014-01-27 |
2019-12-04 |
Molecular Templates, Inc. |
De-immunized shiga toxin a subunit effector polypeptides for applications in mammals
|
|
JOP20200096A1
(ar)
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
جزيئات جسم مضاد لـ tim-3 واستخداماتها
|
|
US10421958B2
(en)
|
2014-02-05 |
2019-09-24 |
Molecular Templates, Inc. |
Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
|
|
EP3900738A1
(en)
|
2014-02-08 |
2021-10-27 |
F. Hoffmann-La Roche AG |
Methods of treating alzheimer's disease
|
|
US20170014446A1
(en)
*
|
2014-03-10 |
2017-01-19 |
La Jolla Pharmaceutical Company |
Compositions and methods for administering galectin antagonists
|
|
ES2723774T3
(es)
|
2014-03-11 |
2019-09-02 |
Molecular Templates Inc |
Proteínas que comprenden regiones de unión, regiones efectoras de la subunidad A de toxina Shiga y motivos señal de localización de retículo endoplasmático carboxi terminal
|
|
SI3604333T1
(sl)
|
2014-03-11 |
2021-08-31 |
Molecular Templates, Inc. |
Proteini, ki obsegajo aminoterminalne proksimalne Shiga toksin podenota A efektorske regije in celico-ciljajoče vezavne regije imunogobulinskega tipa, ki so sposobne specifične vezave CD38
|
|
ES3040431T3
(en)
|
2014-03-12 |
2025-10-31 |
Yeda Res & Dev |
Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns
|
|
SG11201607896YA
(en)
|
2014-04-10 |
2016-10-28 |
Pfizer |
2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES
|
|
US10232056B2
(en)
|
2014-04-16 |
2019-03-19 |
Kyowa Hakko Kirin Co., Ltd. |
Method for measuring toxicity of human CSF
|
|
US9737505B2
(en)
|
2014-04-29 |
2017-08-22 |
Glaxosmithkline Intellectual Property Development Limited |
Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
|
|
WO2015176069A2
(en)
|
2014-05-16 |
2015-11-19 |
Synaptec Development Llc |
CLEARANCE OF AMYLOID ß
|
|
EP3137488B1
(en)
|
2014-06-11 |
2019-01-02 |
Molecular Templates, Inc. |
Protease-cleavage resistant, shiga toxin a subunit effector polypeptides and cell-targeting molecules comprising the same
|
|
US20150377905A1
(en)
|
2014-06-25 |
2015-12-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for diagnosis of kawasaki disease
|
|
AR100978A1
(es)
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
EP3161671A4
(en)
|
2014-06-30 |
2017-06-28 |
Microsoft Technology Licensing, LLC |
Managing data with flexible schema
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
US10132818B2
(en)
|
2014-07-08 |
2018-11-20 |
New York University |
Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
|
|
SI3166970T1
(sl)
|
2014-07-10 |
2021-09-30 |
Bioarctic Ab |
Izboljšana A-beta protofibril vezavna protitelesa
|
|
KR102411972B1
(ko)
|
2014-08-04 |
2022-06-23 |
에프. 호프만-라 로슈 아게 |
이중특이적 t 세포 활성화 항원 결합 분자
|
|
TW201618772A
(zh)
|
2014-08-11 |
2016-06-01 |
艾森塔製藥公司 |
Ｂｔｋ抑制劑、ｐｉ３ｋ抑制劑、ｊａｋ－２抑制劑及／或ｂｃｌ－２抑制劑之治療組合物
|
|
JP6736002B2
(ja)
|
2014-08-14 |
2020-08-05 |
国立大学法人広島大学 |
早産および／または低体重児出産のリスク判定を行うための方法およびキット
|
|
JO3663B1
(ar)
|
2014-08-19 |
2020-08-27 |
Merck Sharp & Dohme |
الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين
|
|
JP7072384B2
(ja)
|
2014-09-15 |
2022-05-20 |
ジェネンテック， インコーポレイテッド |
抗体製剤
|
|
TWI599358B
(zh)
|
2014-09-16 |
2017-09-21 |
美國禮來大藥廠 |
組合療法
|
|
WO2016046162A1
(en)
|
2014-09-22 |
2016-03-31 |
Salama Zoser B |
Proline or proline derivatives for the treatment of dementia
|
|
JP2017531571A
(ja)
|
2014-10-01 |
2017-10-26 |
ダウ グローバル テクノロジーズ エルエルシー |
多層構造及びそれから作製される熱成形物品
|
|
US9921230B2
(en)
|
2014-10-08 |
2018-03-20 |
Rhode Island Hospital |
Methods for diagnosis and treatment of concussion or brain injury
|
|
WO2016059453A1
(en)
|
2014-10-16 |
2016-04-21 |
Fundacion Fraunhofer Chile Research |
Biomarkers and therapeutic targets for alzheimer's disease
|
|
WO2016073299A1
(en)
|
2014-11-04 |
2016-05-12 |
Dana-Farber Cancer Institute, Inc. |
Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responses
|
|
PT3221349T
(pt)
|
2014-11-19 |
2021-01-21 |
Axon Neuroscience Se |
Anticorpos tau humanizados na doença de alzheimer
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
WO2016094639A1
(en)
|
2014-12-10 |
2016-06-16 |
Wisconsin Alumni Research Foundation |
Mini-intronic plasmid dna vaccines in combination with lag3 blockade
|
|
US10464999B2
(en)
|
2015-01-28 |
2019-11-05 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
|
SG11201705986QA
(en)
|
2015-01-29 |
2017-08-30 |
Technophage Investigação E Desenvolvimento Em Biotecnologia Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
|
EP3253788A4
(en)
|
2015-02-06 |
2018-08-08 |
Cell IDX, Inc. |
Antigen-coupled immunoreagents
|
|
TWI669314B
(zh)
|
2015-02-26 |
2019-08-21 |
美國禮來大藥廠 |
針對ｔａｕ之抗體及其用途
|
|
GB201504432D0
(en)
|
2015-03-17 |
2015-04-29 |
Electrophoretics Ltd |
Materials and methods for diagnosis and treatment of alzheimers disease
|
|
EP3274010B1
(en)
|
2015-03-27 |
2019-10-02 |
Eliaz Therapeutics, Inc. |
Patient selective apheresis
|
|
GB201505239D0
(en)
|
2015-03-27 |
2015-05-13 |
Neuro Bio Ltd |
Antibody
|
|
US12109346B2
(en)
|
2015-03-27 |
2024-10-08 |
Eliaz Therapeutics, Inc. |
Galectin-3 plasmapheresis therapy
|
|
ES2914243T3
(es)
|
2015-04-15 |
2022-06-08 |
Anaptysbio Inc |
Anticuerpos dirigidos contra el receptor de la interleuquina 36 (IL-36R)
|
|
AU2016257929B2
(en)
|
2015-05-04 |
2022-10-20 |
Cytomx Therapeutics, Inc |
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
|
|
CN107592812A
(zh)
|
2015-05-11 |
2018-01-16 |
豪夫迈·罗氏有限公司 |
治疗狼疮性肾炎的组合物和方法
|
|
GB201508276D0
(en)
|
2015-05-14 |
2015-06-24 |
Electrophoretics Ltd |
A casein kinase 1 delta inhibitor
|
|
UY36692A
(es)
|
2015-05-29 |
2016-12-30 |
Abbvie Inc |
Anticuerpos anti-cd40 y usos de los mismos
|
|
MX2017015493A
(es)
|
2015-05-30 |
2018-02-09 |
Molecular Templates Inc |
Andamiajes de la subunidad a de la toxina shiga desinmunizados y moleculas con direccion a las celulas que los comprenden.
|
|
JP6979877B2
(ja)
|
2015-06-08 |
2021-12-15 |
デビオファーム インターナショナル， エス． アー． |
抗ｃｄ３７イムノコンジュゲートおよび抗ｃｄ２０抗体の組み合わせ
|
|
US10203342B2
(en)
|
2015-06-11 |
2019-02-12 |
Nanosomix, Inc. |
Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
|
|
ES2809728T3
(es)
|
2015-06-24 |
2021-03-05 |
Hoffmann La Roche |
Anticuerpos anti-tau(pS422) humanizados y procedimientos de uso
|
|
IL302486A
(en)
|
2015-06-24 |
2023-06-01 |
Hoffmann La Roche |
Antibodies against the transnephrine receptor with adapted affinity
|
|
SG10201913518XA
(en)
|
2015-06-30 |
2020-02-27 |
Nanotics Llc |
Compositions and methods related to scavanger particles
|
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
FI3334761T3
(fi)
|
2015-08-13 |
2023-08-14 |
Univ New York |
Vasta-ainepohjaisia molekyylejä, jotka ovat selektiivisiä Taun {p}Ser404-epitoopille, ja niiden käyttöjä tauopatian diagnosoinnissa ja hoidossa
|
|
JP6913078B2
(ja)
|
2015-08-13 |
2021-08-04 |
ニューヨーク・ユニバーシティ |
タウの短縮型Ａｓｐ４２１エピトープに特異的な、抗体を基にした分子、ならびにタウ異常症の診断および治療におけるそれらの使用
|
|
EP3827846B1
(en)
|
2015-08-18 |
2024-10-02 |
Rakuten Medical, Inc. |
Compositions, combinations and related methods for photoimmunotherapy
|
|
IL319047A
(en)
|
2015-08-28 |
2025-04-01 |
Amunix Operating Inc |
Chimeric polypeptide composition and methods for its preparation and use
|
|
CA2997947A1
(en)
|
2015-09-09 |
2017-03-16 |
The Trustees Of Columbia University In The City Of New York |
Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease
|
|
EP3353214B1
(en)
|
2015-09-25 |
2021-08-18 |
Universität Duisburg-Essen |
Agents inhibiting kallikrein-8 for use in the prevention or treatment of alzheimer's disease
|
|
US10358497B2
(en)
|
2015-09-29 |
2019-07-23 |
Amgen Inc. |
Methods of treating cardiovascular disease with an ASGR inhibitor
|
|
JP6657392B2
(ja)
|
2015-10-02 |
2020-03-04 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
二重特異性抗ヒトｃｄ２０／ヒトトランスフェリン受容体抗体及び使用方法
|
|
AR106189A1
(es)
|
2015-10-02 |
2017-12-20 |
Hoffmann La Roche |
ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
|
|
WO2017075119A1
(en)
|
2015-10-28 |
2017-05-04 |
The Trustees Of The Univeresity Of Pennsylvania |
Intrathecal administration of adeno-associated-viral vectors for gene therapy
|
|
EP3374368B1
(en)
|
2015-11-09 |
2022-06-01 |
Galecto Biotech AB |
1,1'-sulfanediyl-di-beta-d-galactopyranosides as inhibitors of galectins
|
|
IL257696B2
(en)
|
2015-12-09 |
2024-11-01 |
Hoffmann La Roche |
Type ii anti-cd20 antibody for reducing formation of anti-drug antibodies
|
|
EP3397645A1
(en)
|
2015-12-28 |
2018-11-07 |
Innate Pharma |
VARIABLE REGIONS FOR NKp46 BINDING PROTEINS
|
|
CA3010027A1
(en)
|
2015-12-28 |
2017-07-06 |
Massachusetts Institute Of Technology |
Bispecific antibodies having constant region mutations and uses therefor
|
|
EP3416661A4
(en)
|
2016-02-18 |
2020-03-04 |
Enlivex Therapeutics Ltd. |
COMBINATION OF IMMUNOTHERAPY AND CYTOKINE CONTROL THERAPY FOR THE TREATMENT OF CANCER
|
|
JP2019517991A
(ja)
|
2016-03-01 |
2019-06-27 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
低減したａｄｃｐを有するオビヌツズマブ及びリツキシマブ変異体
|
|
AU2017236431A1
(en)
|
2016-03-24 |
2018-09-27 |
Bayer Pharma Aktiengesellschaft |
Prodrugs of cytotoxic active agents having enzymatically cleavable groups
|
|
US10894823B2
(en)
|
2016-03-24 |
2021-01-19 |
Gensun Biopharma Inc. |
Trispecific inhibitors for cancer treatment
|
|
WO2017172757A1
(en)
|
2016-03-29 |
2017-10-05 |
Acadia Pharmaceuticals Inc. |
5-ht2a serotonin receptor inverse agonists or antagonists for use in reducing amyloid-beta peptides and accumulation of amyloid plaques
|
|
EP3436037A4
(en)
|
2016-03-31 |
2019-12-04 |
University of Southern California |
HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE-BASED REPORTER TEST FOR ANTIGEN DETECTION
|
|
WO2017180587A2
(en)
|
2016-04-11 |
2017-10-19 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
|
WO2017186928A1
(en)
|
2016-04-29 |
2017-11-02 |
Curevac Ag |
Rna encoding an antibody
|
|
US11326182B2
(en)
|
2016-04-29 |
2022-05-10 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
US9933440B2
(en)
|
2016-05-31 |
2018-04-03 |
Edward J. Goetzl |
Drug efficacy test method for dementias utilizing astrocyte-derived exosomes
|
|
WO2017218911A1
(en)
|
2016-06-17 |
2017-12-21 |
Abbott Laboratories |
BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
|
|
CN118416082A
(zh)
|
2016-06-28 |
2024-08-02 |
应急生物防御行动兰辛有限责任公司 |
布林西多福韦的制剂
|
|
RU2760875C1
(ru)
|
2016-07-12 |
2021-12-01 |
Х. Лундбекк А/С |
Антитела, специфичные к гиперфосфорилированному тау-белку, и способы их применения
|
|
US12123874B2
(en)
|
2016-07-18 |
2024-10-22 |
Cell Idx, Inc. |
Reagent compounds, compositions, kits, and methods for amplified assays
|
|
US10570196B2
(en)
|
2016-07-20 |
2020-02-25 |
Anahit Ghochikyan |
Humanized anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
|
WO2018019188A1
(zh)
|
2016-07-23 |
2018-02-01 |
博瑞生物医药（苏州）股份有限公司 |
核苷氨基磷酸酯类前药的多晶型及其制备方法
|
|
US10730937B2
(en)
|
2016-08-09 |
2020-08-04 |
National University Corporation Tokyo Medical And Dental University |
Antibodies against HMB1, and composition comprising same for treating or preventing alzheimer's disease
|
|
US10076552B2
(en)
|
2016-08-09 |
2018-09-18 |
DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. |
Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
|
|
KR102497742B1
(ko)
|
2016-08-30 |
2023-02-10 |
다나-파버 캔서 인스티튜트 인크. |
약물 전달 조성물 및 그의 용도
|
|
US20190275040A1
(en)
|
2016-09-26 |
2019-09-12 |
Yale University |
Compounds and methods for treating or preventing alzheimer's disease
|
|
US10662226B2
(en)
|
2016-10-28 |
2020-05-26 |
The Regents of the University of Caiifomia |
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
ES2834484T3
(es)
|
2016-11-21 |
2021-06-17 |
Univ Ruhr Bochum |
Método para la preselección de fármacos para enfermedades de plegamiento incorrecto de proteínas
|
|
CA3044682A1
(en)
|
2016-12-02 |
2018-06-07 |
University Of Southern California |
Synthetic immune receptors and methods of use thereof
|
|
AU2017373962B2
(en)
|
2016-12-07 |
2022-03-31 |
Molecular Templates, Inc. |
Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
|
|
WO2018115003A2
(en)
|
2016-12-19 |
2018-06-28 |
Glenmark Pharmaceuticals S.A. |
Novel tnfr agonists and uses thereof
|
|
JP7247091B2
(ja)
|
2016-12-20 |
2023-03-28 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
抗ｃｄ２０／抗ｃｄ３二重特異性抗体と４－１ｂｂ（ｃｄ１３７）アゴニストの併用療法
|
|
MX2019007641A
(es)
|
2016-12-21 |
2019-09-09 |
Bayer Pharma AG |
Conjugados de ligando-farmaco (adcs) con grupos escindibles enzimaticamente.
|
|
US10364286B2
(en)
|
2016-12-22 |
2019-07-30 |
H. Lundbeck A/S |
Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation
|
|
EP3559043A4
(en)
|
2016-12-23 |
2020-08-05 |
Bluefin Biomedicine, Inc. |
ANTI-SEZ6L2 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
|
|
AU2018213194B2
(en)
|
2017-01-25 |
2023-01-12 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising de-immunized, Shiga toxin A Subunit effectors and CD8+ T-cell epitopes
|
|
JP7449092B2
(ja)
|
2017-01-30 |
2024-03-13 |
ナショナル リサーチ カウンシル オブ カナダ |
血液脳関門移動化合物及びその使用
|
|
CN108395482B
(zh)
|
2017-02-08 |
2021-02-05 |
西比曼生物科技（香港）有限公司 |
一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
|
|
US10473672B2
(en)
|
2017-02-09 |
2019-11-12 |
Kaohsiung Chang Gung Memorial Hospital |
Methods for diagnosing and treating Alzheimers disease using G72 protein and SLC7A11 mRNA as biomarkers
|
|
WO2018156250A1
(en)
|
2017-02-21 |
2018-08-30 |
Remd Biotherapeutics, Inc. |
Cancer treatment using antibodies that bind cytotoxic t-lymphocyte antigen-4 (ctla-4)
|
|
US20190374650A1
(en)
|
2017-02-22 |
2019-12-12 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of polymer/biomacromolecule conjugates
|
|
AU2018241624B2
(en)
|
2017-03-27 |
2024-01-25 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
US20230399414A1
(en)
|
2017-03-31 |
2023-12-14 |
Genmab Holding B.V, |
Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof
|
|
EP3601354A1
(en)
|
2017-03-31 |
2020-02-05 |
Genmab Holding B.V. |
Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof
|
|
MY200973A
(en)
|
2017-04-11 |
2024-01-26 |
Inhibrx Inc |
Multispecific Polypeptide Constructs Having Constrained Cd3 Binding And Methods Of Using The Same
|
|
CN108728465A
(zh)
|
2017-04-14 |
2018-11-02 |
深圳新诺微环生物科技有限公司 |
一种表达靶细胞-效应细胞桥接器的微环dna载体及其制备方法和应用
|
|
SG11201909955XA
(en)
|
2017-05-02 |
2019-11-28 |
Merck Sharp & Dohme |
Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
|
|
KR102714455B1
(ko)
|
2017-05-08 |
2024-10-07 |
상하이 제이엠티-바이오 테크노로지 컴퍼니 리미티드 |
이중특이성 재조합단백질 및 이의 응용
|
|
AU2018265813A1
(en)
|
2017-05-12 |
2019-12-05 |
Galectin Sciences, Llc |
Compounds for the treatment of systemic insulin resistance disorders and the use thereof
|
|
AU2018269498A1
(en)
|
2017-05-18 |
2019-10-24 |
F. Hoffmann-La Roche Ag |
Reduction of application-related side reaction of a therapeutic antibody
|
|
MX2019014577A
(es)
|
2017-06-05 |
2020-07-29 |
Janssen Biotech Inc |
Anticuerpos que se unen especificamente a pd-1 y metodos de uso.
|
|
US11214835B1
(en)
|
2017-06-06 |
2022-01-04 |
University Of South Florida |
Methods and compositions for diagnosis and management of neurodegerative diseases
|
|
MA49403A
(fr)
|
2017-06-12 |
2021-03-24 |
Obsidian Therapeutics Inc |
Compositions de pde5 et méthodes d'immunothérapie
|
|
CA3069105A1
(en)
|
2017-07-03 |
2019-01-10 |
Torque Therapeutics, Inc. |
Polynucleotides encoding immunostimulatory fusion molecules and uses thereof
|
|
US10662246B2
(en)
|
2017-07-10 |
2020-05-26 |
New York University |
Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy
|
|
US11220544B2
(en)
|
2017-07-14 |
2022-01-11 |
Cytomx Therapeutics, Inc. |
Anti-CD166 antibodies and uses thereof
|
|
AU2018308088B2
(en)
|
2017-07-25 |
2025-05-29 |
Truebinding, Inc. |
Treating cancer by blocking the interaction of TIM-3 and its ligand
|
|
US20190029970A1
(en)
|
2017-07-31 |
2019-01-31 |
The Chinese University Of Hong Kong |
Fatty acid conjugated nanoparticles and uses thereof
|
|
JP7498108B2
(ja)
|
2017-08-03 |
2024-06-11 |
ガレクティン・サイエンシーズ・リミテッド・ライアビリティ・カンパニー |
医学的障害の予防および治療のための化合物およびその使用
|
|
CN111032692A
(zh)
|
2017-08-08 |
2020-04-17 |
豪夫迈·罗氏有限公司 |
一种dlbcl患者亚组的奥滨尤妥珠单抗治疗
|
|
CN107881160A
(zh)
|
2017-08-11 |
2018-04-06 |
百奥泰生物科技(广州)有限公司 |
一种由基因组被编辑的cho宿主细胞产生的具有独特糖谱的重组抗体及其制备方法
|
|
JP2021500861A
(ja)
|
2017-09-27 |
2021-01-14 |
ユニバーシティ オブ サザン カリフォルニア |
共刺激のための新規のプラットフォーム、新規のｃａｒ設計、および養子細胞療法のための他の増強
|
|
EP3466975A1
(en)
|
2017-10-05 |
2019-04-10 |
Laboratoire Français du Fractionnement et des Biotechnologies |
A specific binding molecule directed against galectin-3 protein
|
|
US20200330592A1
(en)
|
2017-10-09 |
2020-10-22 |
Keith Black |
Compositions and methods of treating alzheimer's and other amyloid related diseases
|
|
AU2018350992A1
(en)
|
2017-10-18 |
2020-05-21 |
Regenxbio Inc. |
Fully-human post-translationally modified antibody therapeutics
|
|
CN118772271A
(zh)
|
2017-10-25 |
2024-10-15 |
爱兰细胞技术公司 |
H1.0k180me2抗体、其制造方法和用途
|
|
AU2018361991A1
(en)
|
2017-10-31 |
2020-05-14 |
Galectin Sciences, Llc |
Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof
|
|
WO2019094679A1
(en)
|
2017-11-10 |
2019-05-16 |
The Regents Of The University Of California |
BRAIN DELIVERY OF THE BACE INHIBITOR SAPPALPHA, ANTIBODIES, OR INHIBITORY RNA's USING SYNTHETIC EXOSOMES (DEFORMABLE NANOVESICLES, DNVs)
|
|
PE20211453A1
(es)
|
2017-11-29 |
2021-08-05 |
Prothena Biosciences Ltd |
Formulacion liofilizada de un anticuerpo monoclonal contra transtirretina
|
|
BR112020011431A2
(pt)
|
2017-12-06 |
2020-11-24 |
Basf As |
derivados de ácido graxo para o tratamento de esteato-hepatite não alcoólica
|
|
CN111492243B
(zh)
|
2017-12-21 |
2024-11-01 |
豪夫迈·罗氏有限公司 |
用于新颖抗原结合模块的特异性测试的car-t细胞测定法
|
|
CN109985231A
(zh)
|
2018-01-02 |
2019-07-09 |
上海清流生物医药科技有限公司 |
一种蛋白在制备预防和治疗痴呆症的药物中的应用
|
|
WO2019137922A1
(en)
|
2018-01-09 |
2019-07-18 |
Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie |
Modulators of c1q, in particular of the interaction of apoe with c1q, and uses of the modulators in the therapy of neuronal diseases and inflammation
|
|
KR101868343B1
(ko)
|
2018-01-16 |
2018-06-18 |
재단법인대구경북과학기술원 |
콧물 시료의 베타 아밀로이드 올리고머를 이용한 알츠하이머 질환의 진행 단계 스크리닝용 조성물 및 이를 이용한 알츠하이머 질환의 진행 단계 스크리닝 방법
|
|
US12180285B2
(en)
|
2018-02-01 |
2024-12-31 |
Memorial Sloan Kettering Cancer Center |
Antibodies to galectin-3 and methods of use thereof
|
|
US12398201B2
(en)
|
2018-02-19 |
2025-08-26 |
New York University |
Tau single domain antibodies
|
|
WO2019165240A1
(en)
|
2018-02-23 |
2019-08-29 |
Rhnanopharma |
Nanosuspensions of salsalate and methods of using the same
|
|
JP7084569B2
(ja)
|
2018-02-23 |
2022-06-15 |
トゥルーバインディング，インコーポレイテッド |
Ｖｉｓｔａ及びその結合パートナーの相互作用を遮断することによる癌治療
|
|
CN112272677B
(zh)
|
2018-02-26 |
2024-10-29 |
米纳瓦生物技术公司 |
使用抗muc1＊抗体的诊断方法
|
|
NL2020520B1
(en)
|
2018-03-02 |
2019-09-12 |
Labo Bio Medical Invest B V |
Multispecific binding molecules for the prevention, treatment and diagnosis of neurodegenerative disorders
|
|
MX2020009991A
(es)
|
2018-03-28 |
2020-10-14 |
Axon Neuroscience Se |
Metodos basados en anticuerpos para detectar y tratar la enfermedad de alzheimer.
|
|
KR20210018789A
(ko)
|
2018-03-29 |
2021-02-18 |
마이크로바스큘러 테라퓨틱스 엘엘씨 |
알츠하이머 병을 검출하고 치료하기 위한 조성물 및 방법
|
|
CN112584901A
(zh)
|
2018-04-04 |
2021-03-30 |
真和制药有限公司 |
用于阻断非糖基化的pd-1多肽之间的相互作用的方法和组合物
|
|
IL323061A
(en)
|
2018-04-11 |
2025-10-01 |
Inhibrx Biosciences Inc |
Multispecific polypeptide constructs with forced CD3 binding and related methods and uses
|
|
JP7318948B2
(ja)
|
2018-04-13 |
2023-08-01 |
国立大学法人京都大学 |
微生物由来化合物を用いたアルツハイマー病の予防、治療、または診断薬
|
|
MA52545B1
(fr)
|
2018-04-16 |
2024-08-30 |
F. Hoffmann-La Roche Ag |
Anticorps pour radionucléides chélatés
|
|
EP3784274A1
(en)
|
2018-04-27 |
2021-03-03 |
Fondazione Ebri Rita Levi-Montalcini |
Antibody directed against a tau-derived neurotoxic peptide and uses thereof
|
|
US11085935B2
(en)
|
2018-05-03 |
2021-08-10 |
Washington University |
Methods of treating based on site-specific tau phosphorylation
|
|
EP3793686A1
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
WO2019231957A1
(en)
|
2018-05-30 |
2019-12-05 |
National Health Research Institutes |
Anti-abeta antibodies and uses thereof
|
|
WO2019241315A1
(en)
|
2018-06-12 |
2019-12-19 |
Obsidian Therapeutics, Inc. |
Pde5 derived regulatory constructs and methods of use in immunotherapy
|
|
PL3810128T3
(pl)
|
2018-06-19 |
2023-01-30 |
Universidad Pablo De Olavide |
Kompozycje do leczenia i/lub zapobiegania chorobom związanym z agregacją białek
|
|
US12280063B2
(en)
|
2018-06-20 |
2025-04-22 |
Sanford Burnham Prebys Medical Discovery Institute |
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
|
|
BR112021000392A2
(pt)
|
2018-07-11 |
2021-04-06 |
Momenta Pharmaceuticals, Inc. |
Composições e métodos relacionados a construtos do domínio de ligação fc-antígeno manipulados
|
|
CA3107370A1
(en)
|
2018-07-24 |
2020-01-30 |
Eisai R&D Management Co., Ltd. |
Methods of treatment and prevention of alzheimer's disease
|
|
CN112584863B
(zh)
|
2018-08-17 |
2025-10-28 |
Ab工作室有限公司 |
催化抗体和其使用方法
|
|
EP3845559A4
(en)
|
2018-08-31 |
2022-12-28 |
Bloom Technology Corporation |
ANTIBODIES FOR ADVANCED GLYCATION TERMINAL PRODUCTS AND THEIR USE
|
|
CN113164572A
(zh)
|
2018-09-11 |
2021-07-23 |
华盛顿大学 |
抗trem-2激动剂抗体
|
|
BR112021005086A2
(pt)
|
2018-09-18 |
2021-06-08 |
1Globe Biomedical Co., Ltd. |
tratamento para doença hepática gordurosa não alcoólica
|
|
JP7475687B2
(ja)
|
2018-09-21 |
2024-04-30 |
国立大学法人 東京医科歯科大学 |
ヒトｈｍｇｂ１に特異的に結合するヒトモノクローナル抗体、及びそれを含有するアルツハイマー病を治療又は予防するための医薬組成物
|
|
EP3861023A1
(en)
|
2018-10-04 |
2021-08-11 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Humanised anti-n-truncated amyloid beta monoclonal antibody
|
|
WO2020069621A1
(en)
|
2018-10-04 |
2020-04-09 |
University Of Manitoba |
Novel biomarker for alzheimer's disease in human
|
|
US11208485B2
(en)
|
2018-10-11 |
2021-12-28 |
Inhibrx, Inc. |
PD-1 single domain antibodies and therapeutic compositions thereof
|
|
CN112867731A
(zh)
|
2018-10-18 |
2021-05-28 |
基本制药有限公司 |
调节nmda受体介导的毒性的新方法
|
|
EP3643319A1
(en)
|
2018-10-25 |
2020-04-29 |
Grifols Worldwide Operations Limited |
Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages
|
|
EA202191179A1
(ru)
|
2018-10-29 |
2021-09-09 |
Байоджен Ма Инк. |
Гуманизированные и стабилизированные варианты fc5 для улучшения транспорта через гематоэнцефалический барьер
|
|
US11925659B2
(en)
|
2018-10-29 |
2024-03-12 |
Cyclo Therapeutics, Inc. |
Methods for treating Alzheimer's disease
|
|
CN111153995B
(zh)
|
2018-11-07 |
2020-12-25 |
上海怀越生物科技有限公司 |
Nkg2a抗体及其制备方法和应用
|
|
US20230132366A9
(en)
|
2018-11-26 |
2023-04-27 |
Denali Therapeutics Inc. |
Methods for treating dysregulated lipid metabolism
|
|
WO2020113164A1
(en)
|
2018-11-30 |
2020-06-04 |
Memorial Sloan Kettering Cancer Center |
Heterodimeric tetravalency and specificity antibody compositions and uses thereof
|
|
CN113412089A
(zh)
|
2018-12-04 |
2021-09-17 |
脑部保护私人有限公司 |
包括用于治疗病症的可植入阻尼装置和治疗剂的组合疗法及相关系统和使用方法
|
|
WO2020123492A1
(en)
|
2018-12-10 |
2020-06-18 |
New York University |
Monoclonal antibodies targeting c-terminal region of phosphorylated tau
|
|
WO2020127618A1
(en)
|
2018-12-21 |
2020-06-25 |
F. Hoffmann-La Roche Ag |
Tumor-targeted agonistic cd28 antigen binding molecules
|
|
JP2022037257A
(ja)
|
2018-12-27 |
2022-03-09 |
クリニジェン株式会社 |
アルツハイマー病を治療又は予防する為の抗ウイルス剤及びその使用
|
|
AU2020207962A1
(en)
|
2019-01-18 |
2021-07-22 |
University Of Southern California |
Methods and compositions to improve the safety and efficacy of cellular therapies
|
|
WO2020154475A1
(en)
|
2019-01-23 |
2020-07-30 |
Molecular Templates, Inc. |
Proteins comprising modified immunoglobulin variable light chains
|
|
JP2022523333A
(ja)
*
|
2019-01-30 |
2022-04-22 |
トゥルーバインディング，インコーポレイテッド |
抗ｇａｌ３抗体およびその使用
|
|
CN111518205B
(zh)
|
2019-02-01 |
2022-03-29 |
长春金赛药业有限责任公司 |
人源化抗Aβ单克隆抗体及其应用
|
|
KR20210125048A
(ko)
|
2019-02-08 |
2021-10-15 |
에이씨 이뮨 에스.에이. |
인산화 타우 펩티드 백신의 안전한 투여 방법
|
|
JP7681316B2
(ja)
|
2019-02-08 |
2025-05-22 |
プロセナ バイオサイエンシーズ リミテッド |
タウを認識する抗体
|
|
PL240124B1
(pl)
|
2019-02-21 |
2022-02-21 |
Univ Jagiellonski |
Sposób określania stopnia uszkodzenia nerek pojawiającego się u chorych z cukrzycą
|
|
BR112021016398A2
(pt)
|
2019-02-22 |
2021-11-23 |
Memorial Sloan Kettering Cancer Center |
Anticorpos cd33 e métodos de uso dos mesmos para tratar o câncer
|
|
WO2020176672A1
(en)
|
2019-02-26 |
2020-09-03 |
Cytomx Therapeutics, Inc. |
Combined therapies of activatable immune checkpoint inhibitors and conjugated activatable antibodies
|
|
US20220160710A1
(en)
|
2019-03-08 |
2022-05-26 |
University Of Virginia Patent Foundation |
Compositions and methods for treating or preventing alzheimer's disease
|
|
WO2020191306A1
(en)
|
2019-03-21 |
2020-09-24 |
Immunogen, Inc. |
Methods of preparing cell-binding agent-drug conjugates
|
|
WO2020193644A1
(en)
|
2019-03-26 |
2020-10-01 |
Janssen Pharmaceutica Nv |
ANTIBODIES TO PYROGLUTAMATE AMYLOID-ß AND USES THEREOF
|
|
MX2021011653A
(es)
|
2019-03-29 |
2021-10-22 |
Torque Therapeutics Inc |
Composiciones inmunoterapeuticas y uso de las mismas.
|
|
CN113661172A
(zh)
|
2019-03-29 |
2021-11-16 |
伊缪诺金公司 |
用于抑制异常细胞生长或治疗增生性疾病的细胞毒性双苯并二氮杂䓬衍生物及其与细胞结合剂的缀合物
|
|
CA3132202A1
(en)
|
2019-04-08 |
2020-10-15 |
Phanes Therapeutics, Inc. |
Humanized anti-dll3 chimeric antigen receptors and uses thereof
|
|
CN114173812A
(zh)
|
2019-04-24 |
2022-03-11 |
杨森制药公司 |
Tau疫苗的异源给予
|
|
BR112021021156A2
(pt)
|
2019-04-24 |
2022-02-08 |
Regenxbio Inc |
Terapêuticos anticorpos totalmente humanos pós-tradução modificados
|
|
IL286846B2
(en)
|
2019-04-26 |
2025-06-01 |
Immunogen Inc |
Camptothecin derivatives
|
|
JP7675441B2
(ja)
|
2019-05-06 |
2025-05-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
移植拒絶反応の非ｈｌａマーカー
|
|
EP3965798A4
(en)
|
2019-05-09 |
2023-06-14 |
University of the Witwatersrand, Johannesburg |
METHOD OF REDUCING THE CONCENTRATION OF TAU (T) PROTEIN AND/OR PHOSPHORYLATED TAU (T) PROTEIN
|
|
JP7550794B2
(ja)
|
2019-05-14 |
2024-09-13 |
ジェネンテック， インコーポレイテッド |
濾胞性リンパ腫を処置するための抗ｃｄ７９ｂ免疫複合体の使用方法
|
|
WO2020236679A1
(en)
|
2019-05-17 |
2020-11-26 |
Cytomx Therapeutics, Inc. |
Methods and compositions for determining the biodistribution of activatable anti-cd166 antibody conjugates
|
|
TW202110891A
(zh)
|
2019-06-04 |
2021-03-16 |
美商維西歐製藥公司 |
抗psgl-1組合物及其用於調節骨髓細胞發炎表型之方法及用途
|
|
CN112111012B
(zh)
|
2019-06-20 |
2023-07-04 |
成都恩沐生物科技有限公司 |
共价多特异性抗体
|
|
US20220227815A1
(en)
|
2019-06-21 |
2022-07-21 |
University Of Kansas |
Compositions and methods useful in treating brain diseases
|
|
CN115175933A
(zh)
|
2019-06-26 |
2022-10-11 |
阿穆尼克斯制药公司 |
Cd3抗原结合片段和包含其的组合物
|
|
CN114401744B
(zh)
|
2019-06-26 |
2024-11-05 |
纪念斯隆凯特琳癌症中心 |
用于治疗癌症的抗cd33抗体
|
|
KR20220027993A
(ko)
|
2019-06-28 |
2022-03-08 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
알츠하이머 질환을 치료하기 위한 방법 및 조성물
|
|
MA56466A
(fr)
|
2019-07-01 |
2022-05-11 |
Eisai R&D Man Co Ltd |
Anticorps anti-epha4
|
|
US20220267776A1
(en)
|
2019-07-05 |
2022-08-25 |
University Of Florida Research Foundation, Incorporated |
Methods for treating ran protein-associated neurological diseases
|
|
JP7194085B2
(ja)
|
2019-07-09 |
2022-12-21 |
日立Astemo株式会社 |
操舵制御装置、操舵制御方法、及び操舵制御システム
|
|
EP3999169A4
(en)
|
2019-07-15 |
2023-09-06 |
Cochlear Limited |
TRANSCUTANEOUS DATA AND ENERGY COMMUNICATION LINK
|
|
CA3147239A1
(en)
|
2019-07-16 |
2021-01-21 |
Sanofi |
Neutralizing anti-amyloid beta antibodies for the treatment of alzheimer's disease
|
|
EP4002490A4
(en)
|
2019-07-17 |
2023-04-05 |
Kabushiki Kaisha Toshiba |
SOLAR BATTERY MODULE AND TANDEM SOLAR BATTERY
|
|
DE102019119426A1
(de)
|
2019-07-17 |
2021-01-21 |
Endress+Hauser SE+Co. KG |
Feldgerät der Automatisierungstechnik
|
|
US20220275037A1
(en)
|
2019-07-19 |
2022-09-01 |
Dingding MO |
ß-AMYLOID CYCLIC RIBONUCLEIC ACID, POLYPEPTIDE, AND APPLICATION THEREOF
|
|
US11142586B2
(en)
|
2019-08-07 |
2021-10-12 |
Aqualung Therapeutics |
Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies
|
|
CA3149433A1
(en)
|
2019-08-14 |
2021-02-18 |
Boehringer Ingelheim Rcv Gmbh & Co Kg |
Caspase-2 variants
|
|
AU2020336440A1
(en)
|
2019-08-30 |
2022-03-24 |
Qilu Puget Sound Biotherapeutics Corporation |
Anti-CD20 antibodies, anti-CD37 antibodies, and mixtures thereof
|
|
CN114450292B
(zh)
|
2019-09-09 |
2024-07-23 |
武汉友芝友生物制药股份有限公司 |
断裂型内含肽、使用其的重组多肽的制备方法
|
|
JP7696335B2
(ja)
|
2019-09-09 |
2025-06-20 |
スクライブ・セラピューティクス・インコーポレイテッド |
免疫療法に使用するための組成物および方法
|
|
US20220402979A1
(en)
|
2019-09-09 |
2022-12-22 |
Axon Neuroscience Se |
Biomarkers and treatments of alzheimer's disease and mild cognitive impairment
|
|
EP4438057A3
(en)
|
2019-09-12 |
2025-01-01 |
F. Hoffmann-La Roche AG |
Compositions and methods of treating lupus nephritis
|
|
US11202068B2
(en)
|
2019-09-16 |
2021-12-14 |
Mediatek Inc. |
Method and apparatus of constrained cross-component adaptive loop filtering for video coding
|
|
JP7749543B2
(ja)
|
2019-09-17 |
2025-10-06 |
オハイオ・ステイト・イノベーション・ファウンデーション |
ヒト抗ｐｄ－ｌ１ペプチドワクチン及びその使用方法
|
|
US20220372142A1
(en)
|
2019-09-19 |
2022-11-24 |
Igm Biosciences, Inc. |
Multimeric antibodies with enhanced selectivity for cells with high target density
|
|
US20240050562A1
(en)
|
2019-10-04 |
2024-02-15 |
Chugai Seiyaku Kabushiki Kaisha |
Inhibitor of cell proliferation in obinutuzumab resistant cd20-positive cancer, and medicinal composition, medicine, production, method for inhibiting cell proliferation, therapeutic method, type ii anti-cd20 antibody, compounds, combination of same, enhancer and inducer, each relating thereto
|
|
EP4041308A1
(en)
|
2019-10-07 |
2022-08-17 |
University of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
|
CN112641953A
(zh)
|
2019-10-10 |
2021-04-13 |
复旦大学 |
一种靶向功能分子修饰的抗体复合物
|
|
JP2022553329A
(ja)
|
2019-10-22 |
2022-12-22 |
バイオジェン・エムエイ・インコーポレイテッド |
アルツハイマー病を治療するための抗ベータ－アミロイド抗体
|
|
ES2821599A1
(es)
|
2019-10-24 |
2021-04-26 |
Univ Del Pais Vasco / Euskal Herriko Unibertsitatea |
Compuestos y metodos para el tratamiento de la enfermedad de alzheimer
|
|
US20220402998A1
(en)
|
2019-10-30 |
2022-12-22 |
The Texas A&M University System |
Protease switch for dual targets chimeric antigen receptor t cell therapy
|
|
GB201915855D0
(en)
|
2019-10-31 |
2019-12-18 |
Univ Oxford Innovation Ltd |
An extracellular vesicle
|
|
CA3157605A1
(en)
|
2019-11-13 |
2021-05-20 |
Volker Schellenberger |
Barcoded xten polypeptides and compositions thereof, and methods for making and using the same
|
|
CN114761438A
(zh)
|
2019-11-28 |
2022-07-15 |
麦克马斯特大学 |
用于编程细胞外囊泡的重组多肽
|
|
CN115279789A
(zh)
|
2019-12-06 |
2022-11-01 |
真和制药有限公司 |
破坏gal3和胰岛素受体或整联蛋白的相互作用的抗体及其使用方法
|
|
US20230046007A1
(en)
|
2019-12-17 |
2023-02-16 |
Cirlo Gmbh |
Tubular shaped elongated catheter device assemblies for interacting with components of bodily fluids, method for recovering cells, cell aggregates and exosomes from a tubular shaped elongated catheter device and smart tubular shaped elongated catheter device assemblies for monitoring interaction with components of bodily fluids
|
|
US11913945B2
(en)
|
2020-01-02 |
2024-02-27 |
Hoffmann-La Roche Inc. |
Method for determining the amount of a therapeutic antibody in the brain
|
|
AU2021207461A1
(en)
|
2020-01-13 |
2022-09-01 |
Truebinding, Inc. |
Anti-Gal3 antibodies and methods of use
|
|
KR20220131279A
(ko)
|
2020-01-21 |
2022-09-27 |
상하이 헨리우스 바이오테크, 인크. |
항lag3단일 클론 항체 및 그 제조 방법과 응용
|
|
CN115380047A
(zh)
|
2020-01-29 |
2022-11-22 |
印希比股份有限公司 |
Cd28单结构域抗体及其多价和多特异性构建体
|
|
TWI853145B
(zh)
|
2020-02-05 |
2024-08-21 |
日商住友製藥股份有限公司 |
Tau蛋白病變及失智症相關疾病之判定藥及判定方法
|
|
IL295122A
(en)
|
2020-02-12 |
2022-09-01 |
Scripps Research Inst |
Long-acting gm-csf and methods of use
|
|
WO2021163681A2
(en)
|
2020-02-14 |
2021-08-19 |
The Trustees Of Columbia University In The City Of New York |
Combination of retromer pharmacological chaperones and exogenous retromer for the treatment of alzheimer's disease and other neurodegenerative diseases and disorders
|
|
WO2021167723A1
(en)
|
2020-02-17 |
2021-08-26 |
Board Of Regents, The University Of Texas System |
Chimeric scavenger receptors targeted to phosphorylated tau (ptau) and uses thereof
|
|
EP4114861A4
(en)
|
2020-03-02 |
2024-05-08 |
The Regents Of The University Of California |
CHIMERIC ANTIGEN RECEPTORS AND RELATED COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
|
|
GB202003428D0
(en)
|
2020-03-10 |
2020-04-22 |
Univ Dundee |
IL-10 mutiens
|
|
CN113384710A
(zh)
|
2020-03-14 |
2021-09-14 |
杭州星鳌生物科技有限公司 |
新型免疫激动剂复合物的组成及其在抗多种疾病药物中的应用
|
|
IL296411A
(en)
|
2020-03-16 |
2022-11-01 |
Univ Southern California |
Novel antigen binding domains and synthetic antigen receptors incorporating them
|
|
CN113402612A
(zh)
|
2020-03-17 |
2021-09-17 |
西比曼生物科技（香港）有限公司 |
靶向cd19和cd20的联合嵌合抗原受体及其应用
|
|
US20230212255A1
(en)
|
2020-03-17 |
2023-07-06 |
Cellular Biomedicine Group Inc. |
Combined chimeric antigen receptor targeting cd19 and cd20 and applications thereof
|
|
US20230104705A1
(en)
|
2020-03-17 |
2023-04-06 |
Cellular Biomedicine Group Inc. |
Combined chimeric antigen receptor targeting cd19 and cd20 and application thereof
|
|
WO2021186079A1
(en)
|
2020-03-20 |
2021-09-23 |
Heidelberg University |
Colloidal carrier systems for transfer of agents to a desired site of action
|
|
US20230107479A1
(en)
|
2020-03-23 |
2023-04-06 |
G3 Pharmaceuticals, Inc. |
Methods and compositions for preventing and treating fibrosis resulting from a coronavirus infection
|
|
TW202342093A
(zh)
|
2020-03-24 |
2023-11-01 |
大陸商深圳瑞健生命科學研究院有限公司 |
一種治療阿茲海默症的方法和藥物
|
|
CA3176937A1
(en)
|
2020-03-24 |
2021-09-30 |
Talengen International Limited |
Method and drug for promoting degradation of misfolded protein and aggregate thereof
|
|
US20230141177A1
(en)
|
2020-03-31 |
2023-05-11 |
The University Of British Columbia |
Antibodies to misfolded amyloid beta
|
|
CA3174646A1
(en)
|
2020-04-07 |
2021-10-14 |
Pieter Muntendam |
Methods and compositions for preventing and treating retinal nerve damage
|
|
JP2023522853A
(ja)
|
2020-04-07 |
2023-06-01 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
中枢神経系及び非中枢神経系への治療薬の送達のための合成エキソソームの製造
|
|
WO2021216832A1
(en)
|
2020-04-23 |
2021-10-28 |
Remd Biotherapeutics, Inc. |
Chemokine receptor 4 (cxcr4) antagonist antibodies
|
|
US20230265204A1
(en)
|
2020-04-24 |
2023-08-24 |
Hoffmann-La Roche Inc. |
Enzyme and pathway modulation with sulfhydryl compounds and their derivatives
|
|
CN115916822A
(zh)
|
2020-04-24 |
2023-04-04 |
基因泰克公司 |
使用抗CD79b免疫缀合物的方法
|
|
BR112022023366A2
(pt)
|
2020-05-19 |
2023-05-02 |
Othair Prothena Ltd |
Vacina com múltiplos epítopos para o tratamento de mal de alzheimer
|
|
US12281166B2
(en)
|
2020-05-26 |
2025-04-22 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking Galectin-3
|
|
WO2021242545A1
(en)
|
2020-05-29 |
2021-12-02 |
The Regents Of The University Of California |
Agents and methods for treating tauopathies
|
|
KR20230037532A
(ko)
|
2020-06-02 |
2023-03-16 |
다이내믹큐어 바이오테크놀로지 엘엘씨 |
항-cd93 구축물 및 그의 용도
|
|
CN116529260A
(zh)
|
2020-06-02 |
2023-08-01 |
当康生物技术有限责任公司 |
抗cd93构建体及其用途
|
|
TWI838626B
(zh)
|
2020-06-03 |
2024-04-11 |
美商基利科學股份有限公司 |
Lpa受體拮抗劑及其用途
|
|
US20230235036A1
(en)
|
2020-06-05 |
2023-07-27 |
The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads |
Acvr1 (alk2) receptor inhibition to treat neurological diseases
|
|
KR102225447B1
(ko)
|
2020-06-16 |
2021-03-08 |
부산대학교 산학협력단 |
구강 세균의 군집을 이용한 알츠하이머 진단용 바이오마커 및 이의 용도
|
|
AR122657A1
(es)
|
2020-06-19 |
2022-09-28 |
Hoffmann La Roche |
Moléculas de unión al dominio fc de activación inmunitaria
|
|
IL299215A
(en)
|
2020-06-25 |
2023-02-01 |
Medimmune Ltd |
Prevention of axonal damage through binding of an antibody to amyloid beta 1-42
|
|
US20210403644A1
(en)
|
2020-06-29 |
2021-12-30 |
University Of South Carolina |
Method For The Degradation Of Endogenous Protein
|
|
US20230256092A1
(en)
|
2020-06-30 |
2023-08-17 |
Shionogi & Co., Ltd. |
Combined use of anti-ccr8 antibody and chemotherapeutic agent
|
|
KR20230066317A
(ko)
|
2020-07-10 |
2023-05-15 |
바이오몰레큘러 홀딩스 엘엘씨 |
사면체 항체
|
|
AU2021313128B2
(en)
|
2020-07-20 |
2025-05-22 |
Genentech, Inc. |
Methods for middle down antibody characterization
|
|
WO2022018726A1
(en)
|
2020-07-20 |
2022-01-27 |
Neotx Therapeutics Ltd. |
Superantigen conjugate for use in methods and compositions for treating cancer
|
|
BR112022027096A2
(pt)
|
2020-07-21 |
2023-04-25 |
Amunix Pharmaceuticals Inc |
Composições e métodos relacionados a agentes terapêuticos ativáveis
|
|
KR20230133832A
(ko)
|
2020-07-29 |
2023-09-19 |
다이내믹큐어 바이오테크놀로지 엘엘씨 |
항-cd93 구축물 및 그의 용도
|
|
CN116406295A
(zh)
|
2020-07-30 |
2023-07-07 |
安奈普泰斯生物有限公司 |
针对鱼鳞病的抗白介素36受体（il-36r）疗法
|
|
WO2022026740A1
(en)
|
2020-07-30 |
2022-02-03 |
Unigen, Inc. |
A standardized bioflavonoid composition for regulation of homeostasis of host defense mechanism
|
|
EP4189121A1
(en)
|
2020-08-03 |
2023-06-07 |
Genentech, Inc. |
Diagnostic and therapeutic methods for lymphoma
|
|
WO2022029051A1
(en)
|
2020-08-03 |
2022-02-10 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
AR122129A1
(es)
|
2020-08-07 |
2022-08-17 |
Prothena Biosciences Ltd |
Vacuna de tau para el tratamiento de la enfermedad de alzheimer
|
|
KR20230080397A
(ko)
|
2020-08-07 |
2023-06-07 |
오타이르 프로테나 리미티드 |
알츠하이머 질환을 치료하기 위한 멀티에피토프 백신
|
|
US20230295258A1
(en)
|
2020-08-11 |
2023-09-21 |
Kanaph Therapeutics Inc. |
Fusion protein comprising il-12 and anti-fap antibody, and use thereof
|
|
MX2023002511A
(es)
|
2020-08-28 |
2023-04-20 |
Harbour Biomed Us Inc |
Anticuerpo anti-ccr8 y aplicacion del mismo.
|
|
CA3161919A1
(en)
|
2020-09-01 |
2022-03-10 |
Remegen Co., Ltd. |
Anti-c-met antibody-drug conjugate and applications thereof
|
|
AU2021345451A1
(en)
|
2020-09-17 |
2023-04-13 |
Othair Prothena Limited |
Beta-amyloid vaccine for the treatment of alzheimer's disease
|
|
CA3192387A1
(en)
|
2020-09-18 |
2022-03-24 |
Othair Prothena Limited |
Multiepitope vaccine for the treatment of alzheimer's disease
|
|
EP4213946A1
(en)
|
2020-09-18 |
2023-07-26 |
Pieris Pharmaceuticals GmbH |
Biomarker methods and uses
|
|
CN116322691A
(zh)
|
2020-09-24 |
2023-06-23 |
豪夫迈·罗氏有限公司 |
T细胞双特异性抗体相关不良反应的预防或减轻
|
|
WO2022072538A1
(en)
|
2020-09-30 |
2022-04-07 |
Biotheryx, Inc. |
Antibody-drug conjugates, pharmaceutical compositions thereof, and their therapeutic applications
|
|
KR20230104617A
(ko)
|
2020-10-07 |
2023-07-10 |
드렌 바이오, 인크. |
항-덱틴-1 항체 및 이의 사용 방법
|
|
MX2023004349A
(es)
|
2020-10-16 |
2023-08-22 |
Lanova Medicines Ltd |
Anticuerpos monoclonales anti-ccr8 y sus usos.
|
|
EP4237449A1
(en)
|
2020-10-28 |
2023-09-06 |
F. Hoffmann-La Roche AG |
Improved antigen binding receptors
|
|
KR20230107235A
(ko)
|
2020-11-10 |
2023-07-14 |
에프. 호프만-라 로슈 아게 |
T 세포 관여제 관련 부정적인 효과의 예방 또는 완화
|
|
EP4259201A4
(en)
|
2020-12-08 |
2025-03-19 |
Memorial Sloan Kettering Cancer Center |
Antibodies to galectin-3 and methods of use thereof
|
|
CN114656562B
(zh)
|
2020-12-23 |
2023-11-03 |
北京天广实生物技术股份有限公司 |
结合人和猴cd3的抗体及其应用
|
|
IL304067A
(en)
|
2021-01-06 |
2023-08-01 |
Hoffmann La Roche |
Combined treatment using PD1-LAG3 bispecific antibody and CD20 T cell bispecific antibody
|
|
WO2022150644A1
(en)
|
2021-01-08 |
2022-07-14 |
Anaptysbio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for acne
|
|
US20240084021A1
(en)
|
2021-01-08 |
2024-03-14 |
Anaptysbio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for hidradenitis suppurativa
|
|
EP4284824A4
(en)
|
2021-01-27 |
2025-03-12 |
AbelZeta Inc. |
CHIMERIC ANTIGEN RECEPTORS TARGETING CD20
|
|
EP4286406A4
(en)
|
2021-01-29 |
2025-07-23 |
Illimis Therapeutics Inc |
FUSION MOLECULE WITH NON-INFLAMMATORY PHAGOCYTOSIS-INDUCING ACTIVITY
|
|
CA3208717A1
(en)
|
2021-02-19 |
2022-08-25 |
Preet M. Chaudhary |
Single-chain and multi-chain synthetic antigen receptors for diverse immune cells
|
|
MX2023010812A
(es)
|
2021-03-15 |
2023-09-27 |
Genentech Inc |
Composiciones y metodos para tratar la nefritis lupica.
|
|
TW202300179A
(zh)
|
2021-03-18 |
2023-01-01 |
美商西根公司 |
內化的生物活性化合物偶聯物選擇性釋放藥物
|
|
US12036286B2
(en)
|
2021-03-18 |
2024-07-16 |
Seagen Inc. |
Selective drug release from internalized conjugates of biologically active compounds
|
|
CN117355319A
(zh)
|
2021-03-23 |
2024-01-05 |
皮里斯制药有限责任公司 |
用于癌症治疗的her2/4-1bb双特异性融合蛋白
|
|
WO2022200478A1
(en)
|
2021-03-24 |
2022-09-29 |
Pieris Pharmaceuticals Gmbh |
Tumor treatment with a 4-1bb/her2-bispecific agent and a her2-targeted tyrosine kinase inhibitor
|
|
WO2022204282A1
(en)
|
2021-03-24 |
2022-09-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Bicistronic chimeric antigen receptors designed to reduce retroviral recombination and uses thereof
|
|
US20240199750A1
(en)
|
2021-03-26 |
2024-06-20 |
Innate Pharma |
Multispecific proteins comprising an nkp46-binding site, a cancer antgienge binding site fused to a cytokine for nk cell engaging
|
|
EP4314050A4
(en)
|
2021-04-02 |
2025-02-26 |
The Board of Trustees of the Leland Stanford Junior University |
BISPECIFIC MOLECULES AND RELATED COMPOSITIONS AND METHODS
|
|
MX2023012364A
(es)
|
2021-04-20 |
2023-11-01 |
Seagen Inc |
Modulacion de citotoxicidad celular dependiente de anticuerpos.
|
|
EP4326271A1
(en)
|
2021-04-23 |
2024-02-28 |
F. Hoffmann-La Roche AG |
Prevention or mitigation of nk cell engaging agent-related adverse effects
|
|
EP4329804A4
(en)
|
2021-04-26 |
2025-03-19 |
TrueBinding, Inc. |
Anti-gal3 antibody formulations and methods of use thereof
|
|
MX2023012408A
(es)
|
2021-04-30 |
2023-10-31 |
Hoffmann La Roche |
Dosis para tratamiento conjunto con anticuerpo biespecifico anti-cd20/anti-cd3 y conjugado anticuerpo farmaco anti-cd79b.
|
|
TW202244059A
(zh)
|
2021-04-30 |
2022-11-16 |
瑞士商赫孚孟拉羅股份公司 |
用抗ｃｄ２０／抗ｃｄ３雙特異性抗體進行治療之給藥
|
|
WO2022235622A2
(en)
|
2021-05-04 |
2022-11-10 |
Biocove Llc |
Cd20 targeting fusion proteins and methods of use thereof
|
|
MX2023013264A
(es)
|
2021-05-12 |
2023-11-30 |
Genentech Inc |
Metodos para usar inmunoconjugados anti-cd79b para tratar linfoma difuso de linfocitos b grandes.
|
|
US20240285740A1
(en)
|
2021-05-12 |
2024-08-29 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating cancer
|
|
CA3218343A1
(en)
|
2021-05-12 |
2022-11-17 |
Anaptysbio, Inc. |
Antibody composition
|
|
WO2022251850A1
(en)
|
2021-05-28 |
2022-12-01 |
Seagen Inc. |
Anthracycline antibody conjugates
|
|
AR126009A1
(es)
|
2021-06-02 |
2023-08-30 |
Hoffmann La Roche |
Moléculas agonistas de unión al antígeno cd28 que se dirigen a epcam
|
|
CN118139641A
(zh)
|
2021-06-04 |
2024-06-04 |
Xencor股份有限公司 |
结合cd20和cd3的双重特异性抗体的剂量施用
|
|
JP2024524870A
(ja)
|
2021-06-08 |
2024-07-09 |
トゥルーバインディング，インコーポレイテッド |
抗ｇａｌ３抗体およびインスリン抵抗性に使用する方法
|
|
WO2022258691A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkg2d, a cytokine receptor, a tumour antigen and cd16a
|
|
EP4351733A1
(en)
|
2021-06-09 |
2024-04-17 |
Innate Pharma |
Multispecific antibodies binding to cd20, nkp46, cd16 and conjugated to il-2
|
|
AU2022288037A1
(en)
|
2021-06-09 |
2023-12-14 |
Shanghai Epimab Biotherapeutics Co., Ltd. |
Antibodies and bispecific binding proteins that bind ox40 and/or pd-l1
|
|
KR20240019297A
(ko)
|
2021-06-09 |
2024-02-14 |
이나뜨 파르마 에스.에이. |
Nkp46, 사이토카인 수용체, 종양 항원 및 cd16a 에 결합하는 다중특이적 단백질
|
|
WO2022258678A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkp30, a cytokine receptor, a tumour antigen and cd16a
|
|
AU2022294106A1
(en)
|
2021-06-18 |
2024-01-25 |
Therini Bio, Inc. |
ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN γC DOMAIN AND METHODS OF USE
|
|
EP4355772A4
(en)
|
2021-06-18 |
2025-07-30 |
Therini Bio Inc |
ANTIBODIES THAT BIND TO THE ?C DOMAIN OF HUMAN FIBRIN OR FIBRINOGEN AND METHODS OF USE
|
|
US20240189341A1
(en)
|
2021-06-22 |
2024-06-13 |
Remegen Co., Ltd. |
Pharmaceutical combination and use thereof
|
|
JP2024527288A
(ja)
|
2021-06-25 |
2024-07-24 |
ナンキン イムノファージ バイオテック カンパニー リミテッド |
抗ｃｃｒ８抗体及びその使用
|
|
US20230201365A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Modified cd20 antibodies and uses thereof
|
|
US20230201364A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Antibody conjugates and manufacture thereof
|
|
EP4370555A4
(en)
|
2021-07-13 |
2025-11-12 |
Truebinding Inc |
METHODS FOR PREVENTING PROTEIN AGGREGATION
|
|
US20230197278A1
(en)
|
2021-07-13 |
2023-06-22 |
Genentech, Inc. |
Multi-variate model for predicting cytokine release syndrome
|
|
EP4370541A1
(en)
|
2021-07-14 |
2024-05-22 |
2seventy bio, Inc. |
Engineered t cell receptors fused to binding domains from antibodies
|
|
CN117730102A
(zh)
|
2021-07-22 |
2024-03-19 |
豪夫迈·罗氏有限公司 |
异二聚体Fc结构域抗体
|
|
US20240336697A1
(en)
|
2021-08-07 |
2024-10-10 |
Genentech, Inc. |
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma
|
|
WO2023019216A2
(en)
|
2021-08-13 |
2023-02-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for diagnosing and treating ischemic eye disease
|
|
CN118591388A
(zh)
|
2021-09-29 |
2024-09-03 |
摩德斯医疗股份有限公司 |
抗原结合多肽、抗原结合多肽复合物及其使用方法
|
|
MX2024003808A
(es)
|
2021-09-29 |
2024-06-11 |
Modex Therapeutics Inc |
Polipeptidos de union a antigeno, complejos de polipeptidos de union a antigeno y metodos de uso de los mismos.
|
|
WO2023051727A1
(zh)
|
2021-09-30 |
2023-04-06 |
上海君实生物医药科技股份有限公司 |
结合cd3的抗体及其用途
|
|
AR127271A1
(es)
|
2021-10-09 |
2024-01-03 |
Hutchmed Ltd |
Anticuerpos biespecíficos que se unen específicamente a cd47 y cd20, y usos de los mismos
|
|
CN115746134A
(zh)
|
2021-10-15 |
2023-03-07 |
深圳市睿盟创新生物科技有限公司 |
半乳糖凝集素-3的免疫测定
|
|
KR20230060546A
(ko)
|
2021-10-22 |
2023-05-04 |
상트네어바이오사이언스 주식회사 |
두개의 Fc 도메인을 포함하는 항원 결합 단백질 및 이의 용도
|
|
EP4423125A1
(en)
|
2021-10-29 |
2024-09-04 |
Zielbio, Inc. |
Cancer specific plectin-1 specific antibodies and methods of use thereof
|
|
JP2024544508A
(ja)
|
2021-11-09 |
2024-12-03 |
トゥルーバインディング，インコーポレイテッド |
心臓血管疾患を治療または阻害する方法
|
|
AU2022397540A1
(en)
|
2021-11-25 |
2024-05-16 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
TW202342105A
(zh)
|
2021-12-17 |
2023-11-01 |
大陸商北京加科思新藥研發有限公司 |
包含可用作sting激動劑的化合物的化合物-連接基構建體及其用途
|
|
US20250368744A1
(en)
|
2021-12-23 |
2025-12-04 |
Concept To Medicine Biotech Co., Ltd. |
Anti-ccr8 antibodies and uses thereof
|
|
EP4458861A1
(en)
|
2021-12-29 |
2024-11-06 |
Sichuan Huiyu Pharmaceutical Co., Ltd. |
Antibody targeting cd3, multispecific antibody, and uses thereof
|
|
WO2023137387A2
(en)
|
2022-01-12 |
2023-07-20 |
Biomolecular Holdings Llc |
Tetrahedral antibodies
|
|
WO2023137373A1
(en)
|
2022-01-12 |
2023-07-20 |
Biomolecular Holdings Llc |
Tetrahedral antibodies
|
|
JP2025508317A
(ja)
|
2022-01-20 |
2025-03-26 |
上海君▲実▼生物医▲薬▼科技股▲分▼有限公司 |
抗ｃｄ３及び抗ｃｄ２０二重特異性抗体、並びにその使用
|
|
CN119053342A
(zh)
|
2022-01-21 |
2024-11-29 |
礼进生物医药控股有限公司 |
用于亲合力受体交联和免疫调节的多特异性抗体
|
|
KR20230119859A
(ko)
|
2022-02-08 |
2023-08-16 |
연세대학교 산학협력단 |
신규 이중타겟 융합항체를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물
|
|
TW202400643A
(zh)
|
2022-02-28 |
2024-01-01 |
日商帝人製藥股份有限公司 |
神經退化性疾病之治療劑
|
|
GB202203070D0
(en)
|
2022-03-04 |
2022-04-20 |
Iksuda Therapeutics Ltd |
Anti-canag antibody conjugate
|
|
EP4493223A2
(en)
|
2022-03-17 |
2025-01-22 |
Seagen Inc. |
Camptothecin conjugates
|
|
CN116789820A
(zh)
|
2022-03-18 |
2023-09-22 |
北京天诺健成医药科技有限公司 |
一种新型免疫调节剂的开发和应用
|
|
KR20240164782A
(ko)
|
2022-03-23 |
2024-11-20 |
에프. 호프만-라 로슈 아게 |
항-cd20/항-cd3 이중특이적 항체와 화학요법의 병용 치료
|
|
EP4499685A1
(en)
|
2022-03-25 |
2025-02-05 |
CytomX Therapeutics, Inc. |
Activatable dual-anchored masked molecules and methods of use thereof
|
|
WO2023180533A1
(en)
|
2022-03-25 |
2023-09-28 |
Les Laboratoires Servier |
Anti-gal3 antibodies and compositions
|
|
CA3255392A1
(en)
|
2022-04-04 |
2023-10-12 |
Dren Bio Inc |
Anti-Dectin-1 Antibodies and Their Methods of Use
|
|
US20250223364A1
(en)
|
2022-04-04 |
2025-07-10 |
Dren Bio, Inc. |
Multispecific binding proteins that bind dectin-1 and cd20 and methods of use thereof
|
|
CN119546327A
(zh)
|
2022-04-08 |
2025-02-28 |
再生元制药公司 |
多部分受体和信号传导复合物
|
|
CN118974091A
(zh)
|
2022-04-11 |
2024-11-15 |
阿斯利康(瑞典)有限公司 |
T细胞结合蛋白
|
|
AR129062A1
(es)
|
2022-04-13 |
2024-07-10 |
Genentech Inc |
Composiciones farmacéuticas de proteínas terapéuticas y métodos de uso
|
|
KR20250004776A
(ko)
|
2022-04-13 |
2025-01-08 |
에프. 호프만-라 로슈 아게 |
항-cd20/항-cd3 이중특이성 항체의 약학 조성물 및 사용 방법
|
|
CN119365479A
(zh)
|
2022-04-15 |
2025-01-24 |
慕宝盛科生物医药(上海)有限公司 |
包含Toll样受体激动剂的缀合物
|
|
CN117003872A
(zh)
|
2022-04-28 |
2023-11-07 |
北京天广实生物技术股份有限公司 |
含有突变轻链可变区骨架的单链抗体片段
|
|
CN119546335A
(zh)
|
2022-05-03 |
2025-02-28 |
Xencor股份有限公司 |
治疗淋巴瘤的方法
|
|
WO2023215740A1
(en)
|
2022-05-06 |
2023-11-09 |
Seagen Inc. |
Immunomodulatory antibody-drug conjugates
|
|
IL316140A
(en)
|
2022-05-25 |
2024-12-01 |
Innate Pharma |
NECTIN-4 binding agents
|
|
US20230416412A1
(en)
|
2022-05-31 |
2023-12-28 |
Hoffmann-La Roche Inc. |
Prevention or mitigation of t-cell engaging agent-related adverse effects
|
|
CN117323429A
(zh)
|
2022-07-01 |
2024-01-02 |
广东克冠达医药科技有限公司 |
Cd101的抗体及其用途
|
|
CN119630428A
(zh)
|
2022-07-12 |
2025-03-14 |
西托姆克斯治疗公司 |
Epcam免疫缀合物及其用途
|
|
WO2024026407A1
(en)
|
2022-07-28 |
2024-02-01 |
The Board Of Regents Of The University Of Oklahoma |
Biomarkers, diagnostic methods, treatments, and therapeutics for autoimmune disorders and diseases
|
|
AR130111A1
(es)
|
2022-08-03 |
2024-11-06 |
Seagen Inc |
Conjugados de anticuerpo y fármaco inmunoestimuladores
|
|
WO2024036148A1
(en)
|
2022-08-08 |
2024-02-15 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating blood cancers
|
|
EP4321522A1
(en)
|
2022-08-12 |
2024-02-14 |
Seagen Inc. |
Cytotoxic compounds and conjugates thereof
|
|
EP4572772A1
(en)
|
2022-08-17 |
2025-06-25 |
Capstan Therapeutics, Inc. |
Conditioning for in vivo immune cell engineering
|
|
CN117051537A
(zh)
|
2023-07-03 |
2023-11-14 |
五邑大学 |
一种乙酰化葡甘聚糖静电纺丝膜及其制备方法与应用
|